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ABSTRACT
Silica exposure has been associated with formation o f autoantibodies and development
o f several autoimmune diseases, however, mechanisms leading to these events are
unknown. Therefore, the effect o f silica on autoimmune disease progression in
autoimmune-prone New Zealand mixed mice was studied. Following silica exposure,
NZM mice developed high levels o f proteinuria and died prematurely due to immune
complex and complement deposition within the glomerulus o f the kidney as compared to
saline and TiOa exposed mice. Further, silica exposure resulted in higher levels o f
autoantibodies to nuclear antigen, specifically histones, than saline or TiOa exposed mice.
These effects were mediated in part by the migration o f high numbers o f CD4+ T cells
and B la B cells to local lymph nodes as well as the decrease in the number of
CD4+CD25+ regulatory T cells. Silica exposure induced a shift in the Thl/Th2 balance
in favor o f a Thl response as measured by alterations in immunoglobulin isotypes. The
increase in autoantibodies following silica exposure in NZM mice involved
autoantibodies which preferentially recognized apoptotie cells. Following silica
exposure, alveolar macrophages from NZM mice were shown to have increased gene
expression levels of several apoptosis genes. Most prominent was an increase in proapoptotic protein kinase C6 in alveolar macrophages from silica exposed NZM mice.
Using an in vitro model, PKC6 was found to mediate apoptosis in silica treated bone
marrow derived macrophages. Further, TN F-a was found to be chronically elevated in
lung lavage fluid possibly adding to the induction o f apoptosis. Inhibiting the apoptotie
response induced by silica in alveolar macrophages using an inhibitor o f PKC6 in vivo
significantly reduced silica exacerbated systemic autoimmune disease. Inhibition o f
PKC5 in vivo resulted in decreased proteinuria, kidney disease and anti-histone
autoantibodies. These results suggest that silica exposure resulted in apoptosis o f alveolar
macrophages and by blocking apoptosis through PKC6 the exacerbation o f systemic
autoimmune disease in NZM mice was inhibited. These data taken together may provide
insights into mechanisms by which xenobiotics induce apoptosis and the role apoptosis
may play in the progression o f systemic autoimmune disease.
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INTRODUCTION
Relatively little is known regarding mechanisms associating environmental
exposures with the development o f autoimmune disease. However, several
environmental factors have been implicated in initiating or accelerating systemic
autoimmune disease including mercury, iodine, vinyl chloride, certain pharmaceuticals
and crystalline silica. In addition, there is increasing epidemiological evidence
supporting the hypothesis that occupational silica exposure is associated with a variety o f
systemic autoimmune diseases, including scleroderma (SSc), rheumatoid arthritis (RA),
systemic lupus erythematosus (SLE), glomerulonephritis (GN) and small vessel vasculitis
(SVV) (Steenland and Brown 1995; Steenland and Goldsmith 1995; 1997; Parks 1999;
Parks 2002; Parks 2003). However, there have been few mechanistic studies examining
silica exposure and autoimmune disease initiation and progression. This introduction will
cover background information on systemic autoimmune diseases and human
epidemiology data linking crystalline silica exposure with autoimmune disease. Further,
this introduction will cover mechanisms o f apoptosis and how silica induced apoptosis
may be involved in the progression o f autoimmune disease. Finally, background data on
the effects o f silica on lymphocytes will be presented followed by specific aims o f this
dissertation.
Systemic Autoimmune Disease
Systemic autoimmune diseases are characterized by immune dysregulation
resulting in the production o f autoantibodies, circulating immune complexes and
activation o f the complement system. These collections o f diseases, which includes
systemic lupus erythematosus, rheumatoid arthritis and scleroderma, can involve the
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joints, skin, kidney, brain, lung, heart and gastrointestinal tract. The pathological
hallmark o f these diseases is recurrent, widespread and diverse vascular lesions due to
immune complex and complement deposition. Women appear to have higher incidences
o f systemic autoimmune diseases, often accounting for greater than 75% o f the cases.
The etiology o f many autoimmune diseases remains unknown. A genetic
predisposition, sex hormones and environmental triggers likely contribute to the
development and progression o f auto immunity. A role for genetics is suggested by
increased frequency o f several MHC haplotypes in patients with autoimmune disease
(NIH 2003). The role for heredity is further supported by a high concordance for
autoimmune disease among monozygotic twins. However, the concordance rate o f
autoimmune disease among polyzygotic twins is only between 25 and 40%, thereby
suggesting a role for environmental factors (NIH 2003).
Crystalline Silica
Commonly known as quartz, crystalline silica is an abundant mineral found in
rock, sand and soil. The highest exposures to silica occur in the dusty trades, such as
mining, farming, foundry work, ceramic and pottery making, glass making, drilling and
sandblasting. Silica is widely used in materials, such as, absorbents, dessicants, catalysts,
fillers, lubricants, thickening agents, paints, etc. Prolonged or acute high exposures o f
silica can cause pulmonary inflammation and fibrosis, which is termed silicosis (1997).
The potential to develop silicosis depends on the concentration o f silica in the ambient
air, the content o f crystalline silica in inhaled dust, the size of the particles (under 1 pm
being most fibrogenic) and the duration and dose o f exposure (Hughes 1982).
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Silica occurs in crystalline and amorphous forms with the crystalline form being
more biologically active. Cutting, grinding and milling o f silica probably results in the
formation o f fractured crystal resulting in the generation o f Si and S i-0 radicals on its
surface. Thus, fractured crystalline silica may have surface properties that make it more
reactive in the lung. Crystalline silica has been shown to have a negative charge on its
surface which provides an increased potential to adsorb and interact with cellular
components (Castranova 1996).
Silica particles o f respirable size, generally less than 1 pm are deposited in the
alveolar spaces o f the lung. The particles are phagocytosed by alveolar macrophages
which are removed by the mucociliary movement o f macrophages up the respiratory tract
or drained to the lymphatics (Brody 1982). However, at high concentrations it is reported
that the mucociliary clearance o f silica particles is impaired resulting in an accumulation
o f silica laden macrophages within the lymphatics and interstitial spaces o f the lung
(Brody 1982). Consequently, these silica-laden macrophages are able to interact with
other immune cells, possibly mediating many o f the immune effects o f silica, including
systemic autoimmune disease.
Silica Exposure and Autoimmune Disease (Human Data)
There have long been case reports linking silica exposure to several autoimmune
diseases, however recently there have been several population based studies examining
silica exposure as a risk for the development o f autoimmune disease (Parks 1999; Parks
2002; Parks 2003). Parks et al (2002) reported a higher prevalence o f systemic lupus
erythematosus (SLE) in patients following silica exposure than a control population.
Further, they reported an association between the level o f silica exposure and the
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development o f SLE. These data suggest that silica exposure may promote the
development o f SLE in some individuals and that the development o f disease may be
more prevalent in highly exposed individuals. They further examined several common
types o f autoantibodies and found a strong association between silica exposure and antiDNA and anti-Sm autoantibody levels. An association between silica exposure and anti
neutrophil cytoplasmic autoantibody formation has also been reported to be involved in
small vesicle vasculitis (Hogan 2001). Therefore, it appears that silica exposure results in
the production o f several specific types o f autoantibodies.
Lymphocytes have been examined in regards to activation and abnormalities in
patients with silicosis and these same abnormalities may play a role in the progression o f
autoimmune disease. The number o f T helper cells was reported to be increased in the
lymph nodes o f the lung hilus in silicosis patients, however, the overall number o f all
classes o f T lymphocytes was decreased (Watanabe 1987). Further, silicosis patients who
were reported to have a higher prevalence o f autoimmune disease also had a significant
decrease in B, T and NK cells as compared to healthy volunteers (Subra 2001). Although
a significant increase in the percentage o f activated CD3+ T cells was reported (Subra
2001). However, it is not known whether the increase o f activated T cells represents
chronic stimulation by silica and if this is occurring directly or indirectly through other
immune cells or cytokines. Further, it is not known if the overall decrease in B, T and
NK cells is due to apoptosis o f these cells. Decreased numbers o f lymphocytes
(lymphopenia) have been reported to induce autoimmune diseases experimentally
through reduction o f regulatory T cells that help control T helper cell responses.
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Therefore, this may provide an additional mechanism for the effects o f silica on the
immune system (Shevach 2000).
As mentioned above, there is strong evidence linking silica exposure with several
autoimmune diseases. While these data may provide clues to underlying mechanisms
involved in silica-induced autoimmunity, there are relatively little data examining
detailed mechanisms in animal models that may then be applied to therapeutic
intervention.
Silica and Apoptosis
Apoptosis, or programmed cell death, has several possible roles in the
pathogenesis o f autoimmune disease; including generation of apoptotie material as a
source o f antigen, altered immune cell apoptosis as a cause o f immune dysregulation and
tissue specific apoptosis as a mechanism o f organ specific autoimmune disease. Possible
mechanisms o f silica induced autoimmune disease may involve apoptosis o f the alveolar
macrophage, an immune cell o f the lung that is the first line o f defense and a cell
involved in the clearance o f apoptotie cells. It has previously been reported that uptake
o f silica leads to apoptosis of alveolar macrophages and appears to be in part mediated
through scavenger receptor class A (SR-A) (Iyer 1996; Thibodeau 2003). SR-A is
characterized by broad ligand binding specificity and is referred to as a pattern
recognition receptor. SR-A has been mainly studied for its role in atherosclerosis due to
the binding o f modified low density lipoproteins (Krieger 1997). However, silica has
also been reported to bind SR-A (Kobzik 1995). Silica induced apoptosis o f alveolar
macrophages leads to release and uptake o f silica by other alveolar macrophages,
producing a cyclical process o f inflammation and cell death (Cooper 2002). This may
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provide an environment o f excess antigen being presented to the immune system, thereby
breaking immune tolerance. In support o f this hypothesis, the presence o f concentrated
autoantigens has been reported within the blebs o f apoptotie cells (Rosen and CasciolaRosen 1999). Further, lupus autoantigens are represented by structures that are
chemically cleaved or modified during apoptosis and if this material is not removed by
non-inflammatory processes, apoptotie material could be presented by specialized antigen
presenting cells to induce immune responses (Utz and Anderson 1998; Ronchetti 1999).
In an in vitro system, macrophages were found to prevent immunity to apoptotie material
by competing with dendritic cells for uptake o f apoptotie blebs, demonstrating the
importance o f the cell population silica is targeting for injury (Albert 1998). Consistent
with this hypothesis, animals intravenously exposed to apoptotie cellular material have
been reported to develop autoantibodies (Mevorach 1998). Therefore, it appears
apoptosis may play a role in the development o f autoimmune disease following silica
exposure so mechanisms o f silica-induced apoptosis, including caspase activation,
Fas/Fas ligand and TN F-a will be reviewed.
Silica and Caspase Activation
The central effectors in apoptotie cell death involve the activity o f a group o f
cysteine proteases known as caspases. They are termed caspases because they cleave
their target protein at specific aspartic acid residues. Caspases are synthesized in the cell
as inactive precursors, or procaspases, which are typically activated by cleavage at
aspartic acid residues by other caspases. Once activated, caspases cleave and thereby
activate other procaspases resulting in an amplifying proteolytic cascade. The activated
caspases can then cleave key cellular proteins, such as structural proteins, cell cycle
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proteins, signaling proteins, or they can activate DNA degrading enzymes leading to
apoptosis o f the cell. Thirteen caspases have been identified and are named caspase-1
through -13. Two main pathways of caspase activation have been studied, the intrinsic
and extrinsic pathways.
The intrinsic pathway involves mitochondrial damage resulting in redistribution
o f cytochrome c from the mitochondria to the cytoplasm of the cell. The activation o f
caspases depends on the release o f cytochrome c and the presence o f Apaf-1 (apoptotie
protease activating factor). When cytochrome c is released from the mitochondria, Apaf1 binds caspase-9 in a cytochrome c and ATP dependent manner. The activation o f
caspase-9 by Apaf-l in turn leads to the activation o f caspase-3. Caspase-3 is termed an
effector caspase because it mediates many o f the apoptotie processes.
In addition to activation o f caspases through mitochondrial release o f cytochrome
c and Apaf-1, caspases can be activated through cell surface receptors. The extrinsic
pathway o f caspase activation involves several tumor necrosis factor receptor (TNFR)
family members, such as TNFR-1 and CD95 (Fas). These receptors have an intracellular
signaling domain referred to as the death domain (DD). Upon receptor engagement by
TNF or Fas ligand, the DD is bound by another class o f proteins referred to as adaptor
proteins which can activate caspase-8 and -1 0 . Through downstream events, caspase-8
and -1 0 lead to the cleavage and activation o f caspase-3 which results in apoptosis o f the
cell.
Silica has been reported to alter mitochondrial membrane permeability inducing
release o f procaspase-9 (Thibodeau 2003). Silica has been reported to specifically lead to
the production o f the active p39 subunit o f caspase-9 and not the p37 subunit, which in
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turn leads to cleavage and activation o f caspase-3 thereby initiating apoptosis in MH-S
cells (Thibodeau 2003). Using a general caspase inhibitor (z-VAD-fmk) or a caspase-9
specific inhibitor (z-LEHD-fink), Thibodeau et al (2003) were able to inhibit silica
induced activation o f caspase-9 and -3 in MH-S cells. They further reported that
inhibition o f the mitochondrial permeability pore by cyclosporin A partially decreased
caspase-9 and -3 activation in silica exposed MH-S cells. Therefore, activation o f
caspases by silica appears to be partially dependent on loss o f mitochondrial integrity.
Borges et al (2002) has reported a role for apoptosis in silicosis by using caspase
inhibitors in silica exposed BALB/c mice. Treatment with pan-caspase inhibitors
reduced inflammation and collagen deposition in the lungs o f BALB/c mice that received
20 mg o f silica (Borges 2002). Silica-induced apoptotie cells were also found in the
draining lymph nodes o f these silica-instilled BALB/c mice where they were able to
interact with lymphocytes (Borges 2002). They further reported that within the draining
lymph nodes o f these silica treated mice, electron microscopy showed lymphocytes
undergoing activation induced cell death. Therefore, it appears apoptosis plays a role in
silicosis and that silica-induced apoptotie cells are found outside o f the lung, suggesting a
systemic immune response.
Silica and Fas/FasL
Fas is a cell surface receptor protein involved in apoptosis which belongs to the
TNF receptor family and Fas abnormalities have been reported in human autoimmune
diseases such as SLL and RA. Fas ligand (FasL) induces apoptosis by binding its
membrane receptor Fas. Outside o f the thymus, most o f the T cell receptor mediated
apoptosis o f T cells, referred to as activation induced cell death (AICD) is induced
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through the Fas pathway. Cytotoxic T lymphocytes also have the ability to use FasL to
trigger apoptosis in Fas bearing cells, such as virus infected cells or cancer cells. The
importance of Fas in AICD is demonstrated by the Ipr and gld strains o f mice which have
alterations in the Fas gene. Lpr and gld mice develop a lymphoproliferative disorder that
resembles systemic lupus erythematosus. The MKLHpr and gld mice have been studied
with regards to silicosis, however, no studies have examined autoimmune disease
following silica exposure in these models (Davis 1998; Borges 2002). In MKLHpr mice,
silica has been reported to result in increased prominent cellular infiltrates and fibrosis as
compared to BALB/c or C3H mice which have normal levels o f Fas (Davis 1998).
Borges et al (2002) reported that silica exposed T cells from BA LB.g/J mice were
resistant to AICD as compared to wild-type BALB/c mice suggesting that self-reactive T
cells may be able to escape apoptosis in this silicosis model. Further, silicosis patients
with autoimmune disease have been reported to have elevated serum soluble Fas levels as
compared to healthy volunteers (Otsuki 1998; Tomokuni 1999; Hamzaoui 2003).
Soluble Fas is produced as an altematively spliced product o f the Fas gene which protects
the cell from apoptosis by antagonization o f the binding between membrane bound Fas
and FasL. Therefore, it is possible that self-reactive immune cells may survive by
escaping Fas mediated apoptosis or silica may allow for excess lymphocyte activation
induced cell death leading to immune abnormalities.
Silica and TNF-a
Tumor necrosis factor-a (TN F-a) is a potent cytokine mediator o f inflammatory
and immune functions. TN F-a mediates a broad range o f biological activities, but was
originally characterized by its ability to induce apoptosis o f tumor cells. TN F-a is
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predominately produced by macrophages and signals through TNF receptors which are
found on nearly all cell types. There are two types o f TNFR, type 1 (p55) and type II
(p75). The type I receptor is found on most cells, while the type II receptor is found
mainly on hematopoietic cells. The TNFR has a death domain in the cytoplasmic tail
which signals an adaptor protein named TRADD (TNF receptor associated death
domain). For apoptosis signaling, TRADD recruits FADD (Fas associated death domain)
which in turn recruits and activates caspase-8 and -1 0 . As discussed previously, caspase8 and -1 0 in turn can activate caspase-3 through downstream signaling events leading to
apoptosis.
TN F-a has been studied extensively in silica-induced fibrosis, however, the same
role TN F-a plays in fibrosis may be relevant to silica-induced autoimmune disease.
When macrophages are exposed to silica in vitro, enhanced TN F-a production occurs
(Savici 1994; Ortiz 1999). Increases in TN F-a production activate an inflammatory
cascade which induces release o f cytokines, including TN F-a, and activation o f several
cell signaling cascades (Pfeffer 2003). Inhibition o f TN F-a significantly reduces fibrosis
and addition o f recombinant TN F-a increases collagen deposition in the lungs o f mice
(Piguet 1990; Ortiz 1999). Ortiz et al reported that silica-exposed C57B1/6 and BALB/c
mice upregulated mRNA levels o f TN F-a and the p75 TNFR and that these mice
developed fibrosis. They also reported that silica-exposed TNFR knockout mice did not
develop fibrosis as compared to wild-type mice. Thus, silica induced lung injury
involves TN F-a production and signaling by macrophages. TN F-a has been extensively
studied as a pro-apoptotic cytokine, therefore, it possible that siliea-indueed production o f

10
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TN F-a by macrophages may lead to apoptosis and that apoptosis may be playing a role in
lung injury.
Abnormalities at many points in the process o f apoptosis may be related to
autoimmune disease pathogenesis. Given the amount o f evidence and the many
pathways for the induction o f apoptosis due to silica exposure, it is likely that apoptosis is
playing a role in the progression o f autoimmunity. Figure 1 shows an overview o f
possible silica-indueed signaling pathways involved in apoptosis. Overall these data
suggest that silica-induced apoptosis may provide excess antigen, altered antigen and/or
impaired clearance o f apoptotie material leading to systemic autoimmunity.

11
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Figure 1.
Possible signaling pathways involved in apoptosis o f alveolar macrophages induced by
silica exposure. Possible signaling pathways involve Fas/FasL, TN F-a, PKC8, activation
o f caspases through the mitochondria and signaling through the scavenger receptor.
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Protein Kinase C S
An additional pro-apoptotic protein which was examined in this study following
silica exposure is protein kinase C8 (PKC5) (Fig. 1). PKC8 is a novel PKC family
member that has been reported to play a role in the initiation o f apoptosis in many cell
types (Pongracz 1999; Webb 2000; Bertho 2002; Lounsbury 2002; Brodie and Blumberg
2003; Shukla 2003). PKC6 is activated by diacylglycerol (DAG)/phorbol esters in a
calcium-independent manner. PKC6 activation and translocation are induced by a variety
o f apoptotie stimuli in many different cellular systems. PKC6 is activated in neutrophils
undergoing spontaneous apoptosis, in H202-induced apoptosis, TN F-a induced apoptosis.
Fas mediated apoptosis and asbestos-induced apoptosis o f alveolar epithelial cells
(Pongracz 1999; Webb 2000; Bertho 2002; Lounsbury 2002; Brodie and Blumberg 2003;
Shukla 2003).
As shown in Figure 2, PKC5 is regulated not only by the binding o f DAG or
phorbol ester but also by molecular mechanisms such as phosphorylation and proteolytic
reactions. PKC5 has several conserved serine and threonine phosphorylation m otif sites
as well as three different tyrosine phosphorylation sites which have been reported to be
important in H 2 O 2 induced activation (Konishi 2001; Kikkawa 2002). In addition to
phosphorylation, a catalytically active fragment o f PKC5 is generated by proteolysis in
cells induced to undergo apoptosis in response to anti-Fas, DNA damaging drugs and
ionizing radiation (Emoto 1995; Mizuno 1997; Takahashi 1998). The catalytically active
fragment o f PKC6 is reported to be cleaved by caspase-3 at Asp-327 and is involved in
inhibiting the function o f DNA-dependent kinase thereby contributing to DNA damage
induced apoptosis (Bharti 1998). All three forms o f PKC5 activation have been reported

14
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to lead to apoptosis, however, the targets and cellular localization o f the various activated
PKC6 isoforms may vary (Kikkawa 2002; Basu 2003).
Cell lines have been established that overexpress PKC5 providing a mechanism to
elucidate the role o f PKC8. In general, growth inhibition is observed in cells
overexpressing PKC6 (Kikkawa 2002). H202-induced apoptosis is enhanced in CHO
cells overexpressing PKC6 (Kikkawa 2002). Further, transgenic mice have been
generated that overexpress PKC6 in basal epidermal cells resulting in mice that are
resistant to skin tumor formation induced by phorbol ester (Reddig 1999). In addition to
overexpression o f PKC6, knockout mice have been generated. The PKC6-null mice were
reported to have increased proliferation o f B cells and were prone to autoimmune disease
(Miyamoto 2002). This was attributed to the deficiency o f PKC6 preventing the
establishment o f B cell tolerance through deletion o f self-reactive B cells (Miyamoto
2002). In addition to these immune effects, decreased apoptosis o f smooth muscle cells
was reported to have led to arteriosclerotic lesions in PKC6 deficient mice (Leitges
2001). Even though PKC6 is ubiquitously expressed, it is unclear why PKC5 null mice
only show a clear phenotype in certain cell types.
A study by Shukla et al (2003) reported a role for PKC6 in apoptosis o f alveolar
type II cells induced by exposure to asbestos. They reported that asbestos induced PKC5
leading to its translocation to the mitochondria inducing release o f cytochrome c and
activation o f caspase-9. Pre-treatment o f these cells with rottlerin, a selective inhibitor o f
PKC6, prevented activation o f caspase-9 and apoptosis o f asbestos exposed type II cells
(Shukla 2003). These results suggest that apoptosis o f alveolar type II cells is dependent
on PKC5 and similar mechanisms may be involved in silica-induced apoptosis.

15
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FIGURE 2

Apoptotic Signal
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Figure 2
Diagram o f the activation o f PKCS by three distinct mechanisms: Diacylglycerol (DAG),
caspase-3 and phosphorylation. In addition to activation by DAG, PKCS is activated by
phosphorylation at several serine/threonine and tyrosine residues. PKCS is also cleaved
by caspase-3 to form a catalytically active fragment that is able to translocate to the
nucleus to inhibit DNA protein kinase thereby preventing DNA repair.
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Silica Exposure and Lymphocytes
As discussed previously, silica-induced apoptosis o f alveolar macrophages may
provide excess or modified antigen that is presented to lymphocytes thereby eliciting
autoantibody production and T cell mediated responses. Further, the inflammatory
response initiated by silica provides activation signals via cytokines to lymphocytes.
Several studies have further examined silica’s effects on lymphocytes using animal
models.
Silica exposure has been reported to result in massive increases in lymph node
size and sustained activation o f distinct T cell populations suggesting silica is mitogenic
for T cells (Gam 1997; Davis 2000; Gam 2000). Lymph nodes from silica exposed rats
have been reported to be increased in weight up to 35-fold 52 weeks after siliea exposure
and that the increase was due to an early influx o f CD4+ T cells and later influx o f B cells
(Friedetzky 1998). Six weeks following silica exposure, Friedetzky et al (1998) reported
finding accumulations o f macrophages with ingested silica scattered throughout the
lymphoid tissue and these macrophages were interacting with lymphocytes undergoing
apoptosis. Gam et al (1997) further reported that T cells from lymph nodes o f silieotic
rats had become activated with enhanced IFN-y gene transcription, thereby resulting in
macrophage activation. Gam et al (2000) further examined cytokine production from T
cells in silicotic rats and reported a shift towards production o f the Thl cytokines: IL-12,
lL-18 and IFN-y. Therefore, T cells seem to be migrating into the lymph nodes o f
silicotic animals and are producing cytokines, thereby providing additional signals for
immune activation. Studies using T cell deficient nude mice, have suggested a role for T
lymphocytes in the migration o f macrophages to the lung and in the termination o f a
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neutrophil response following silica exposure (Hubbard 1989). In this study, Hubbard
(1989) reported that silica exposure in nude mice resulted in a massive influx o f
neutrophils that persisted over two months, whereas in the T cell sufficient mice, the
neutrophil response was short lived and followed by a migration o f macrophages into the
lung. This suggests that T cells play a role in influencing the cell type within the lung o f
silica exposed mice, however, the siliea exposed nude mice did not develop fibrosis
(Hubbard 1989). These results suggest that T cells may play a role in the migration o f
macrophages to the lung and that macrophages are playing a major role in the induction
o f the fibrotic process. A similar role for T cells inducing macrophage migration to the
lung may also be an important mechanism for the progression o f autoimmune disease.
Lymphocytes appear to be migrating to regional lymph nodes o f silica-exposed
animals, however antigen-presenting cell and T cell interactions may be occurring within
the lung itself. The accumulation o f lymphocytes has been reported within the alveolar
spaces o f the lung and lymphoid tissue o f silica treated C3H/HeN mice (Davis 2001).
These lymphocytes were reported to consist primarily o f CD4+ T cells, but also
numerous CD8+ T cells, NK cells and y6 T cells (Davis 2001). Further, Davis et al
(2001) reported enhanced IFN-y production and mRNA transcripts for IL-12 and IL-18,
thereby suggesting a Thl response in silica-exposed mice. Using IFN-y deficient
C57B1/6, Davis et al (2001) further reported less extensive silicosis than in wild-type
mice. Lymphocytes are found within the lung o f silica-exposed animals, however, very
little data exist as to their role in the progression o f autoimmune disease.
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Taken together, these data suggest that silica exposure results in T and B cell
activation primarily within the draining lymph nodes o f the lung. It appears silica and
apoptotic material-laden antigen presenting cells are migrating to these lymph nodes and
presenting self-antigen to T cells, thereby inducing autoimmune responses. The
activation of T cells can then lead to B cell activation and autoantibody production
further inducing immune complex formation and complement activation.
New Zealand M ixed Mouse Model o f Autoimmune Disease
Several mouse models o f systemic autoimmune disease exist, however, many o f
the models have a rapid and severe onset o f disease, thereby masking any potential to
observe environmental effects. The New Zealand mixed (NZM) mouse is a genetically
mixed hybrid o f the N ew Zealand white X New Zealand black Fi (NZWxNZB F i)
crossed with a NZW father mouse. Several lines o f autoimmune prone NZM mice were
generated from this breeding, o f which the NZM2410 is the most studied (Rudofsky and
Lawrence 1999). NZM2410 mice were selected due to the presence o f renal disease and
development o f autoantibodies. NZM2410 mice do not have a full complement of
autoimmune genes as with other mouse models o f autoimmunity, but do carry many
susceptibility loci. Thus, an environmental effect may be more readily observed in this
moderately autoimmune prone strain rather than strains o f mice with high disease
penetrance. Rudofsky et al (1999) reported that NZM mice develop proteinuria and 50%
o f the mice succumb to glomerulonephritis around

6

months o f age. They further

reported that these mice develop autoantibodies to dsDNA, ssDNA, IgG, histones,
chromatin, nuclear antigens, nucleosomes and myeloperoxidase. Thirty percent o f these
mice also develop anti-erythrocyte autoantibodies leading to anemia (Rudofsky and
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Lawrence 1999). Ail NZM strains are deficient in eomplement C4 and C5 thus Rudofsky
et al (1999) have proposed these genes as susceptibility loci. Due to the lower disease
penetranee in the NZM2410 mouse model, it provides an appropriate model to assess the
effects o f silica on the development o f autoimmune disease.
Specific Aims
Using the autoimmune prone New Zealand mixed mouse model, this project
examined the ability o f silica exposure to exacerbate systemic autoimmune disease in a
genetically susceptible population. It is possible that many people have varying levels o f
genetic susceptibility to autoimmune disease, but have not developed the disease,
however an environmental exposure such as silica may push the immune system to a
point at which the susceptibility genes may be involved and a disease results. By
examining the following 3 specific aims, we will better understand mechanisms by which
silica and possibly other relevant environmental agents can alter the immune system
resulting in autoimmunity.
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SPECIFIC AIMS
Specific Aim I.

Characterize the exacerbation o f systemie autoimmune disease by
silica in autoimmune prone-New Zealand mixed miee (Chapters 1
and 2 )

Specific Aim II.

Characterize the role o f apoptosis in the production o f
autoantibodies in silica exposed NZM mice (Chapter 3)

Specific Aim III.

Characterize the role o f protein kinase C 6 in silica-induced
apoptosis arid systemic autoimmune disease in NZM mice
(Chapter 4)
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CHAPTER 1
Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed
mice
Abstract
The genetic backgrounds o f lupus-prone murine models are a valuable resource
for studying the influence o f environmental exposure on autoimmune diseases in
sensitive populations. Epidemiological studies have shown associations between silica
exposure and several autoimmune diseases, including scleroderma and systemic lupus
erythematosus. To determine whether silica exposure can exacerbate systemic
autoimmunity in genetically predisposed animals, New Zealand mixed mice were
intranasally instilled twice with saline or saline suspensions o f 1 mg silica or 500 pg
Ti02, a dose equivalent in surface area, and were evaluated with respect to health and
immune status. Survival in silica exposed NZM mice was decreased compared to saline
and TiOa exposed mice. Proteinuria levels were elevated in silica exposed mice. Levels
of circulating immune complexes, autoantibodies to nuclear antigen (ANA), histone, and
double stranded DNA were measured every two weeks by ELISA. Circulating immune
complexes showed a trend towards an increased acceleration in levels in the silica
exposed mice compared to saline and Ti 0 2 exposed mice. ANA levels were significantly
higher in silica exposed animals compared to saline and Ti 0 2 exposed animals (0.237 ±
0.03 vs. 0.140 ± 0.029 and 0.125 ± 0.03,/? < .05) 16 weeks post-exposure.
Autoantibodies to histone were also significantly elevated after 16 weeks in silica
exposed animals compared to saline and Ti 0 2 exposed animals (0.227 ± 0.03 vs. 0.073 ±
0.015 and 0.05 ± 0.03,p < .05). In contrast, serum IgG levels were decreased in silica
exposed NZM mice compared to the saline controls, however IgM levels were
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unaffected. Lungs o f the silica-exposed mice had increased inflammatory infiltrates as
well as fibrotic lesions characterized by excess collagen deposition. Therefore, although
NZM mice are susceptible to SLE, silica exposure significantly exacerbated the course o f
disease.
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Introduction
Silica is ubiquitous in the environment as an abundant mineral found in rock,
sand, and soil. Occupational silicosis results from acute or chronic exposures to high
levels o f silica dusts in many manufacturing and construction processes as well as mining
operations. Silicosis leads to deceased pulmonary function and increased susceptibility to
other diseases o f the respiratory tract (1997). In addition, inhalation o f silica has been
associated with increased incidence o f systemic autoimmune diseases, such as systemic
lupus erythematosus (SLE) and scleroderma (Parks, Conrad et al. 1999). Human silicosis
patients have exhibited increased autoantibodies, immunoglobulins and immune
complexes (Doll, Stankus et al. 1981). However, the mechanisms leading to
autoantibody production and the relationship to subsequent pathology have not been
elucidated and these autoimmune reactions do not occur in all silica exposed individuals,
suggesting a genetic component. Although some o f the enhanced humoral response
could be attributed to a non-specific adjuvant effect, the tendency towards select
autoimmune syndromes suggests a more specific effect.
A study by Steenland and Brown demonstrated that 3000 gold miners exposed to
silica had increased risk for autoimmune diseases, including SLE, rheumatoid arthritis,
and scleroderma (Steenland and Brown 1995). Haustein and Anderegg created a
scleroderma registry from 1980-1997 and showed a 12-fold increase in scleroderma in
males over the age o f 40 with silicosis (Haustein and Anderegg 1998). Several other
groups have reported an increased incidence o f SLE associated with silicosis (Wilke,
Salisbury et al. 1996; Brown, Gridley et al. 1997).
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The present study was designed to test the hypothesis that silica exposure could
exacerbate the development o f autoimmune disease in a genetically susceptible murine
model. Studies by Pollard, et al have demonstrated that autoimmune prone mice are a
valuable resource for studying the effects o f environmental exposures on genetically
susceptible populations (Pollard, Pearson et al. 1999). The New Zealand mixed (NZM)
2410 mouse model was selected to assess the effects o f silica exposure and the
exacerbation o f predisposed autoimmune disease. NZM mice spontaneously develop
features o f SLE between

6

months and 1 year o f age (Rudofsky and Lawrence 1999).

This model eharaeteristically develops anti-dsDNA, anti-histone, and anti-nuclear antigen
(ANA) autoantibodies as well as increasing levels o f circulating immune complexes
(Rudofsky and Lawrence 1999). This strain also develops glomerulonephritis by one
year of age in 80% o f males and females (Rudofsky and Lawrence 1999). The New
Zealand mixed mouse was incorporated into this study due to the lower number o f
autoimmune susceptibility loci compared with murine models that have a lull
complement o f SLE genes, such as the M RL/lpr or NZBxNZW F I, in which the severe
autoimmune phenotype could mask any environmental insult (Rudofsky and Lawrence
1999).
The overall objeetive o f the study was to test the hypothesis that inhaled silica,
and not saline or a control particle (TiOi), could exacerbate the natural progression o f
systemic autoimmune disease in SLE prone NZM mice. The disease course was
measured by following the development o f autoantihodies, serum immunoglobulins,
immune eomplexes, proteinuria, and pulmonary fibrosis.

Materials and Methods
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Mice
Male and female New Zealand mixed (NZM 2410) mice were obtained from Taconic
(Germantown, NY) and maintained in microisolation containers in accordance with the
Guide fo r the Care and Use o f Laboratory Animals prepared by the Institute o f
Laboratory Animal Resources, National Research Council. The animal room is set on
12

-hour dark/light cycles with food and water provided ad libitum.

Treatment o f mice
At six weeks o f age, mice were instilled intranasally with either 30 pL saline (n=5) or 30
pL saline suspensions o f 1 mg crystalline silica (n=14) or 500 pg TiOa (n=5) as a control
particle equivalent to silica in surface area. All mice received 2 instillations 2 weeks
apart in order to represent several exposures over a period o f time. Control and
experimental groups were matched for the number o f male and female mice. Silica was
obtained from Pennsylvania Glass Sand Corp. (Pittsburgh, PA). Ti 0 2 was obtained from
Fisher Scientific (Denver, CO). Mice were bled for sera before the first instillation and at
2-week intervals following instillations to monitor autoantibody levels. A second cohort
of NZM mice was instilled with 30 pL saline (n= 8 ) or 30 pL o f a saline suspension o f 1
mg silica (n= 8 ) to use for histological examinations at 14 weeks. After 14 weeks, blood
was collected for sera by cardiac puncture. The lungs and kidneys were removed for
histology and the superficial cervical lymph nodes and spleens were weighed.
Detection o f serum autoantibodies
ANA was detected by indirect immunofluoresence using HEp-2 cell slide kits
(Immunoconcepts, Saeramento, CA). Manufacturer’s protocol was followed. ANA,
anti-dsDNA, anti-histone antibodies and circulating immune complexes were detected by

31

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ELISA kits (Alpha Diagnostics, San Antonio, TX). Sera were diluted 100-fold before
assay and manufacturer’s protoeol was followed. Samples with a positive cireulating
immune complex level were determined by using a cut-off value as determined by the
manufacturer. The reported values are mean optical density (OD) values from each
treatment group.
Serum immunoglobulin quantitation
Serum IgG and IgM levels were quantitated by ELISA. 96 well Polysorp Nalge-Nunc
ELISA plates (Fisher) were coated with 100 pL o f 1 pg/mL goat anti-mouse kappa light
chain antibody (Southem Biotechnology Associates, Birmingham, AL) diluted in
phosphate-buffered saline (PBS) and incubated overnight at 4°C. Plates were blocked
with 200 pL PBS-1% bovine serum albumin (BSA) for 1 hour at room temperature
followed by 3 washes with PBS-0.1% Tween 20. Sera were diluted in PBS-0.1% Tween
20/1% BSA. Standard curves were generated using unlabeled IgG (Southern
Biotechnology Associates) starting at 0.5 pg/mL and unlabeled IgM (Sigma Chemical,
St. Louis, MO) starting at 1 pg/mL. Diluted sera were added to wells and incubated in
duplicate for 1 hour at room temperature followed by 3 washes with PBS-0.1% Tween
20. HRP-conjugated goat anti-mouse IgG (Fc-ffagment specific) (Jackson
ImmunoResearch Laboratories, West Grove, PA) and IgM (Jackson Laboratories) were
diluted 2000-fold in PBS-0.1% Tween 20/l% BSA and incubated for 1 hour at room
temperature followed by 3 washes with PBS-0.1% Tween 20. 100 pL One Step TMB
substrate (Zymed, San Francisco, CA) was added and incubated for 15 minutes followed
by the addition o f 100 pL 2N H 2 SO 4 to stop the reaction. The optical density was read at
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450 nm and serum immunoglobulin concentration was calculated by extrapolation from
the linear portion o f the standard curve. All samples were tested in duplicate.
Urinary Protein
Proteinuria was measured by Chemstrip 2 GP test strips as described by the manufacturer
(Boehringer Mannheim Diagnostics, Indianapolis, IN). Milligram protein per deciliter
was measured between groups following the provided scale (0 = negative, trace, 1+ = 30
mg/dL, 2+ = 100 mg/dL, 3+ = 500 mg/dL).
Histology
Animals were given a lethal injection o f sodium pentobarbital (5 mg i.p.) and the lungs
were perfused with Histochoice fixative (Amresco Inc, Solon, IL). Lungs and kidney
were removed and routinely processed using an automated processor (ThermoShandon,
Pittsburgh, PA). The lungs and kidneys were embedded in paraffin wax and sectioned 57 pM thick, then collected on poly-L-lysine coated slides (Sigma Chemical, St. Louis,
MO). Using an automated Stainer (ThermoShandon, Pittsburgh, PA) lung samples were
stained with hematoxylin and eosin for general cellular morphology and Gomori
Triehome for collagen deposition. Samples were blinded and examined by light
microscopy. Kidney sections were immunohistochemically stained using an antibody for
IgG immune complex and complement deposition. The kidney sections were boiled in a
0.01 M sodium citrate buffer for 10 minutes followed by washes in distilled water and
phosphate buffered saline. The kidney sections were then blocked with 4% fetal bovine
serum in phosphate buffered saline. Goat anti-mouse IgG-FITC antibody (ICN
Biomedicals, Irvine, CA) and a goat anti-mouse C3-FITC (ICN Biomedicals, Irvine, CA)
were used for the detection o f immune complexes and complement deposition. A goat
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anti-rat IgG antibody (ICN Biomedicals, Irvine, CA) was used as an isotype control.
Samples were blinded and examined using a fluorescent microscope.
Statistical Analysis
Differences between silica treated and saline or Ti02 treated miee were assessed using
analysis o f variance (ANOVA) and unpaired Mest. All values are reported as mean ±
SE; p < 0.05 was considered significant.
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Results
Effects o f silica and Ti02on mortality, proteinuria and circulating immune complexes in
N ZM mice
Mortality, proteinuria and immune complexes have been reported with silicosis
(Doll, Stankus et al. 1981), therefore these biomarkers were examined in NZM mice
following instillation o f saline or saline suspensions o f Ti02 or silica. Mortality in silica
instilled NZM mice was exacerbated compared to saline and TiOi instilled animals
(Figure 3). Mortality in silica exposed NZM mice began around 10 weeks following
instillation, while mortality in the saline and TiOi instilled mice didn’t begin until 16
weeks following instillation. Within 22 weeks following instillation o f silica, only 22%
o f the mice survived, while 60% o f the mice instilled with saline or TiOa survived within
the same time and continued to live until sacrificed at 9 months following exposure.
Although NZM mice have a rapid onset o f glomerulonephritis with proteinuria
levels greater than 500 mg/dL in both males and females (Rudofsky and Lawrence 1999),
silica exposure exacerbated the development o f proteinuria (Figure 4). NZM mice
instilled with silica developed proteinuria levels o f 500 mg/dL within 10 weeks following
instillation, while the saline instilled mice did not develop the same levels until 16 weeks
following exposure.
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Figure 3.
Survival o f saline (■ ) (n=5), TiOi (-^ ) (n=5) and silica (•) (n=14) instilled NZM
mice. Siliea exposed NZM survival decreased more rapidly and to a greater extent than
saline and TiOi exposed mice.
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The TiOa instilled mice developed 500 mg/dL proteinuria levels 14 weeks following
exposure. Sixteen weeks following exposure, 87.5% o f the silica instilled NZM mice had
500 mg/dL levels o f proteinuria, while only 33% o f saline and TiOa had high proteinuria
levels.
Levels o f circulating immune complexes showed a trend towards accelerated
elevation in silica instilled mice compared to saline and TiOi instilled mice (Figure 5).
The silica instilled NZM mice developed detectable levels of circulating immune
complexes within 6 weeks following instillation, while it required 10 weeks post
exposure for the TiOi exposed mice to develop detectable levels o f circulating immune
complexes. The saline exposed mice did not show detectable levels o f circulating
immune complexes until 12 weeks following instillation. However, within 14 weeks
following exposure, all o f the mice within the three groups developed circulating immune
complexes. 16 weeks following exposure, fewer saline and TiOa exposed mice had
detectable levels o f circulating immune complexes, while all o f the silica exposed mice
continued to have detectable levels o f circulating immune complexes. Taken together,
these results demonstrate that silica exposure in NZM mice exacerbates mortality,
possibly due to increases in proteinuria levels and circulating immune complexes.
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Figure 4.
Proteinuria levels greater than 500 mg/dL in saline (■ ) (n=5), Ti02 ( -^) (n=5) and
silica ( • ) (n=14) instilled NZM mice measured by Chemstrip 2GP proteinuria/glucose
strips every two weeks. Siliea exposed NZM mice developed high proteinuria levels
earlier and in greater numbers than the saline or TiOi exposed mice.
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Figure 5.
Levels o f circulating immune complexes (CIC) in serum from silica exposed NZM mice.
Shown is the percentage o f saline (■ ) (n=5), Ti02 (-*■) (n=5) and silica ( • ) (n=14)
exposed NZM mice that developed a positive level o f CIC measured by ELISA every two
weeks. Serum samples with an OD reading above a certain cut-off value that was set
according to the manufacturer was considered to have positive levels o f CIC.
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Effects o f silica and HO 2 on autoantibody levels in N ZM mice
Although NZM mice are susceptible to autoantibody formation, typically
developing autoantibodies within six months o f age (Rudofsky and Lawrence 1999),
silica significantly elevated levels o f serum ANA and anti-histone antibodies within 16
weeks following exposure compared to saline and TiOi (Figure 6). ANA levels measured
by ELISA were exacerbated in the silica-exposed animals compared to the saline and
Ti02 mice (0.237 ± 0.03 vs. 0.140 ± 0.029 and 0.125 ± 0 . 0 3 , < .05 respectively) (Figure
6A). ANA was also confirmed by HEp-2 fluorescent staining that consisted o f a
homogenous nuclear pattern (Data not shown). Anti-histone antibody levels were also
elevated in silica treated mice compared to saline and Ti02 treated animals (0.227 ± 0.03
vs. 0.073 ± 0.015 and 0.05 ± 0 . 0 3 , < .05 respectively) (Figure 6B). Autoantibodies to
dsDNA were also examined, however there were no differences between treatments (data
not shovm). These results demonstrate that silica exposure is able to elevate levels o f
autoantibody production in an autoimmune prone mouse model.
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Figure 6.
Development o f anti-nuclear antigen (ANA) and anti-histone autoantibodies in saline (■ )
(n=5), TiOi ( -^) (n==5) and silica ( • ) (n=14) exposed NZM mice measured by ELISA
every two weeks. Silica exposure significantly elevated ANA levels 16 weeks following
exposure compared to saline and TiOi (A). Levels o f anti-histone autoantibodies 16
weeks following exposure were also elevated compared to saline and TiOi exposed mice
(B). The values reported are mean values for each treatment group. The levels o f ANA
and anti-histone autoantibodies before 6 weeks were not different between treatments and
therefore not shown. *(p < 0.05 using an unpaired t-test)
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Effects o f silica on serum immunoglobulin levels in N ZM mice
Serum immunoglobulin levels have been reported to be increased in several
models o f silicosis (Huang, Hubbs et al. 2001; Weissman, Hubbs et al. 2001), therefore
IgG and IgM levels were examined in NZM mice following instillations o f saline and
silica. IgM and IgG levels were examined by ELISA using serum from saline and silica
14 week exposed mice that were sacrificed for lung histology. Fourteen weeks following
silica exposure, IgG levels were decreased from an average o f 3024 pg/mL in the saline
exposed mice to 1638 pg/mL in the silica exposed mice (Figure 7). However, the levels
o f IgG remained the same from 2-12 weeks (data not shown). There was no difference
with IgM levels in the saline or silica exposed mice from 2 weeks to 14 weeks following
exposure (data not shown). These results demonstrate that silica exposure specifically
decreases IgG in the NZM mouse model contrary to increases in immunoglobulin levels
in other models o f silicosis.
Effects o f silica on pathological changes in N ZM mice
Saline and silica exposed NZM mice were sacrificed at 14 weeks following
exposure to collect lung samples for histology and to examine lymph node and spleen
weights. Lung sections were stained with H&E and Gomori’s trichrome to examine the
development o f fibrosis. Histological examination o f stained lung sections o f silica
exposed NZM mice revealed fibrotic lesions with excess collagen deposition, while the
saline exposed mice had minimal collagen deposition (Figure 8). H&E staining showed
increased inflammatory infiltrates in the silica exposed NZM mice compared to the saline
exposed mice (data not shown).
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Figure 7.
Serum IgG levels in saline and silica exposed NZM mice 14 weeks following exposure
measured by ELISA. IgG levels were significantly reduced in silica exposed mice (n=8)
compared to saline control mice (n==8) *(p < 0.05 using an unpaired t-test).

48

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

FIGURE 8

1
,

-V , -

B.

^>•'

ijW

_|gr’

\r

0

^fi

. )

_ if T lliri ^

w
iT

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 8.
Representative examples o f Gomori trichrome staining o f a saline (A) and silica (B)
exposed NZM mouse 14 weeks following exposure. The silica exposed mouse shows
extensive fibrotic lesions and excess collagen deposition represented by the blue
staining indicating development o f silicosis. Saline exposed mice had very little collagen
deposition.
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The kidneys o f saline and silica exposed NZM mice were examined 14 weeks
following exposure for the presence o f immune complex and complement deposition.
Immunohistochemical staining o f kidneys revealed extensive IgG immune complex
deposition within the glomeruli o f silica exposed mice (Figure 9). The saline exposed
mice showed minimal staining for IgG immune complexes within the glomeruli. The
kidneys were also_stained for complement C3 deposition and showed similar patterns o f
staining within the glomerulus as the IgG immune complex staining (data not shown).
The superficial cervical lymph node was removed and weighed upon sacrifice o f
saline and silica treated NZM mice. A trend towards an increase in the average size o f
the lymph node in the silica treated mice (117.4 g ± 33.3) compared to the saline treated
mice (69.04 g ± 20.7) was observed. However, there was no difference in spleen weight
between the silica exposed (152 g ± 15.7) and the saline exposed mice (146 g ± 13.3).
These results demonstrate that silica exposure in NZM mice is leading to development of
silicosis with increased inflammation in the lung and increased immune complex and
complement C3 deposition within the kidney.
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Figure 9.
Representative examples o f immunohistoehemical staining o f kidney sections from saline
(A) and silica (B) exposed NZM mice 14 weeks following exposure. A goat anti-mouse
IgG-FITC antibody was used to stain immune complexes within the glomeruli o f the
kidney. The silica-exposed mice showed extensive immune complex deposition within
the glomeruli o f the kidney while the saline exposed mice had minimal staining for
immune complexes. (*Magnified 60x)
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Discussion
The exacerbation o f systemic autoimmune disease by silica exposure in New
Zealand mixed mice identifies a potential model for the study o f xenobiotic effects on
autoimmune susceptible populations. This study demonstrates that silica is able to
exacerbate the development o f autoimmune disease in a genetically susceptible mouse
model. The disease acceleration involved increases in mortality, proteinuria,
autoantibody levels, circulating immune complexes, pulmonary fibrosis, immune
complex deposition and complement C3 deposition within the kidney. The disease
acceleration appears to be specific to silica and is not seen with a control particle, TiOa,
which has been reported to cause mild inflammation (Yuen, Hartsky et al. 1996).
The most pronounced response to silica exposure in the NZM mouse was a
decrease in survival. The siliea exposed NZM mice died significantly earlier than the
saline or TiOi exposed mice, which corresponded with the development o f proteinuria
levels greater than 500 mg/dL. This suggests that mortality may have been associated
with development o f glomerulonephritis in the silica-exposed miee. Silica particles have
been reported to accumulate in the kidney leading to renal fibrosis and localized
inflammation (Slavin, Swedo et al. 1985). However, our model indicates that circulating
autoantibodies are deposited within the kidney resulting in an immune complex mediated
glomerulonephritis. This is supported by the rapid development o f high titers o f
circulating immune complexes, proteinuria and immune complex deposition within the
kidneys o f the silica-exposed miee.
Possible mechanisms o f silica induced autoimmune disease may involve the
alveolar macrophage, the primary immune cell o f the lung that is the first line o f defense

54

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

and the primary cell involved in the clearance o f apoptotic cells within the lung. It has
previously been reported that phagocytosis o f silica leads to a caspase dependent
apoptosis in human alveolar macrophages (Iyer, Hamilton et al. 1996). Silica induced
apoptosis o f alveolar macrophages leads to release and phagocytosis o f silica by other
alveolar macrophages, producing a cyclical process o f inflammation and cell death
(Cooper, Miller et al. 2002). This constant inflammation and cellular death may provide
excess antigen that is being presented to the immune system, thereby breaking immune
tolerance.
In this study, autoantibodies to nuclear antigen, including dsDNA and histone
were examined as biomarkers o f disease acceleration because NZM mice have been
reported to develop high titers o f these within

6

months to 1 year o f age (Rudofsky and

Lawrence 1999). Silica exposure significantly elevated ANA levels and autoantibodies
to histone, but had little effect on dsDNA autoantibody levels. The increase in titers o f
these autoantibodies may be the result o f silica induced apoptosis leading to excess
apoptotic material being presented to the immune system.
Several studies have examined immunoglobulin responses to experimental
silicosis. These studies have reported that silicosis is associated with elevated IgG and
IgM levels in the blood o f Fisher rats (Huang, Hubbs et al. 2001). Another study
examined IgG subclass responses in experimental silicosis, also in Fisher rats, and
reported increased IgG-secreting spot-forming cells o f all IgG subclasses in lung
associated lymph nodes (Weissman, Hubbs et al. 2001). However, our results with NZM
mice show a decrease in IgG levels 14 weeks following silica exposure and no change in
IgM levels from 2 to 14 weeks post-exposure. In spite o f the decrease in total IgG levels
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there was an increase in autoantibodies o f the IgG class. This suggests silica may be
decreasing total IgG, but a higher percentage o f the immunoglobulin appears to be
autoreactive. The decrease in IgG levels may be in part explained by the overall health o f
the mice. The majority o f the silica exposed mice died within 16 weeks o f exposure and
the IgG levels were measured 14 weeks following silica exposure. Severe weight loss
occurred one to two weeks before the silica exposed mice died. It is possible the immune
system was compromised at this point and unable to produce normal levels o f IgG.
However, a trend towards an increase in the size o f the superficial cervical lymph nodes
in the silica-exposed mice was observed, suggesting increased immune activity.
The silica exposed NZM mice developed pulmonary fibrosis, visualized with
Gomori trichrome stain for collagen deposition, while the saline exposed mice did not
develop fibrosis. However, it is unknown whether the fibrosis is due to direct action o f
the silica or could be exacerbated by the increase in autoantibodies and immune
complexes. Future studies will examine if deposition o f immune complexes occurs in
these silicotic lungs. H&E staining further showed significant infiltration o f
inflammatory cells into the lungs o f the silica treated NZM mice. Future studies will
examine which inflammatory cells are being recruited to the lung and the role they may
play in the development o f autoimmune disease. Staining of kidney sections from silica
exposed NZM mice for immune complex and complement C3 deposition revealed
extensive immune complex mediated glomerulonephritis.
In summary, silica exposure in the NZM 2410 mouse model o f SEE appears to accelerate
the development o f autoimmune disease. This exacerbation o f disease involved increased
mortality, proteinuria, autoantibodies, immune complexes, pulmonary fibrosis and
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immune complex mediated glomerulonephritis. The NZM mouse represents a good
model to further study the mechanisms o f xenobiotic induced autoimmune diseases in a
genetically susceptible population.
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CHAPTER 2
Immunoglobulin and lymphocyte responses following silica exposure in New
Zealand mixed miee
Abstract
Epidemiological studies have shown strong associations between silica exposure and
several autoimmune diseases, including scleroderma and systemic lupus erythematosus.
We previously reported that the New Zealand mixed mouse develops silicosis and
exacerbated autoimmunity following crystalline silica exposure, including increased
levels o f autoantibodies, proteinuria, cireulating immune complexes, pulmonary fibrosis
and glomerulonephritis. In this study, the NZM mouse was used to examine changes in
immune activation following silica exposure by measuring levels o f immunoglobulin,
eytokines and lymphocyte populations. Levels o f IgG 1 were significantly decreased
from 1124 ± 244 pg/ml in saline exposed mice to 614 ± 204 pg/ml in silica exposed mice
suggesting a decrease in the Th2 response. The levels o f TN F-a were significantly
increased (1.5 fold) in the bronehoalveolar lavage fluid o f the silica-exposed mice as
compared to the saline exposed mice. The number o f B la B cells were significantly
increased 6 -fold within the superficial cervical lymph nodes o f silica-exposed mice as
eompared with saline exposed miee. Following silica exposure, CD4+ T cells
significantly increased 3-fold within the superficial cervical lymph nodes. During this
increase in the number o f CD4+ T cells, the number o f CD4+CD25+ regulatory T cells
were not significantly changed therefore altering the ratio of regulatory T cells to T
helper cells from 1:5 to 1:8 following silica exposure. Therefore, the silica induced
alterations in immunoglobulin levels, increased TN F-a, inereased B la B cells and CD4+
T cells with deereased regulatory T cells may provide an environment that allows for
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increased autoreactivity. These studies begin to provide possible mechanisms for
environmentally induced autoimmune diseases that have been reported in many
epidemiological studies.
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Introduction
Silica is ubiquitous in the environment as an abundant mineral found in rock, sand and
soil. Silicosis is an occupational disease resulting from acute or chronic high levels of
silica exposure that leads to decreased pulmonary function and increased susceptibility to
other diseases o f the respiratory tract (1997). Silicosis has also been associated with
increased incidence o f systemic autoimmune disease, such as systemic lupus
erythematosus (SLE) and scleroderma (Wilke et al. 1996; Parks et al. 1999; Parks et al.
2002). Human silicosis patients have exhibited increased autoantibodies,
immunoglobulins and immune complexes (Doll et al. 1981). Although some o f the
enhanced humoral response could be attributed to a nonspecific adjuvant effect, the
tendency towards select autoimmune diseases suggests a more specific effect.
Although genetics have been shown to be partly responsible for autoimmune
disease, identical twin studies have consistently found only a 20-30% chance that both
twins will develop autoimmune disease suggesting an environmental component. A
recent study by Parks, et al reported an association between silica exposure and the
development o f SLE in a case control study in the Southeastern United States (Parks et al.
2002). Earlier studies by Steenland and Brovm demonstrated that 3000 gold miners
exposed to silica had increased risk for autoimmune diseases, including SLE, rheumatoid
arthritis and scleroderma (Steenland et al. 1995). Haustein and Anderegg created a
scleroderma registry from 1980 to 1997 and reported a 12-fold increase in scleroderma in
males over the age of 40 with silicosis (Haustein et al. 1998).
Previously, a good animal model o f silicosis with development o f autoimmune
disease has not been available to study these effects, however we recently reported that
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the New Zealand mixed (NZM) mouse develops silicosis and increased autoimmune
disease upon exposure to crystalline silica (Brown et al. 2003). However, the
mechanisms leading to autoantibody production and the relationship to subsequent
pathology have not been elucidated. The silica-exposed mice develop higher levels o f
autoantibodies, proteinuria, circulating immune complexes, pulmonary fibrosis and
glomerulonephritis than saline or titanium dioxide exposed control mice (Brown et al.
2003).
In the present study, the NZM mouse model to examine changes in
immunoglobulin, cytokine and lymphocyte numbers following the exacerbation o f
autoimmunity due to silica exposure. The hypothesis was that NZM mice will exhibit
increased immune activity as measured by increases in immunoglobulin and cytokine
levels as well as increases in lymphocyte numbers following silica exposure that may
play a role in the exacerbation o f autoimmune disease. We conducted studies that
examined alterations in the ratio o f Thl and Th2 immunoglobulin profiles as well as
increases o f cytokines within the lungs o f silica exposed NZM mice. We further
investigated alterations in B and T cell numbers within the spleen and superfieial cervical
lymph node o f silica treated NZM miee. We examined both the B220+ and B la B cell
populations as well as CD4+ T helper eells and CD4+CD25+ T regulatory cell
populations. These studies may provide possible mechanisms for not only silica-induced
autoimmune disease, but also other environmentally relevant particles.
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Materials and Methods
Mice
Male and female New Zealand Mixed (NZM2410) mice were obtained from Taconic
(Germantown, NY) and maintained in microisolator containers in accordance with the
Guide fo r the care and use o f laboratory animals prepared by the Institute o f Laboratory
Animal Resources, National Resource Council. The animal room is set on 12 hour
light/dark cycles with food and water provided ad libitum.
Treatment o f mice
At six weeks o f age, equal numbers o f male and female NZM miee were intranasally
instilled with 30 pL saline (n= 8 ) or 30 pL saline suspensions o f 1 mg crystalline silica
(n= 8 ). All miee received 2 instillations 2 weeks apart in order to represent several
exposures over a period o f time. Siliea was obtained from Pennsylvania Glass Sand
Corp. (Pittsburgh, PA). Miee were bled for sera every two weeks until sacrificed at 14
weeks post-exposure. At 14 weeks blood was collected for sera by cardiac puncture.
Serum immunoglobulin quantitation
Serum IgM, IgG, IgG l, IgG2a, IgG2b, and IgG3 levels were quantitated by ELISA.
Polysorp Nalge-Nune 96 well ELISA plates (Fisher) were coated with 100 pL o f 1
pg/mL goat anti-mouse kappa light chain antibody (Southern Biotechnology Associates,
Birmingham, AL) diluted in phosphate-buffered saline (PBS) and incubated overnight at
4°C. Plates were blocked with 200 pL PBS-1% bovine serum albumin (BSA) for 1 hour
at room temperature followed by 3 washes with PBS-0.1% Tween 20. Sera were diluted
in PBS-0.1% Tween 20/1% BSA. Standard curves were generated using unlabeled IgG
(Southern Biotechnology Associates) starting at 0.5 pg/mL, unlabeled IgM (Sigma
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Chemical, St. Louis, MO) starting at 1 |ag/mL, unlabeled IgG l (Southern Biotechnology
Associates) starting at 0.1 |o.g/mL, unlabeled IgG2a (Sigma) starting at 0.25 |ag/mL,
unlabeled IgG2b (Southern Biotechnology Associates) starting at 0.05 |J.g/mL, unlabeled
IgGS (Sigma) starting at 0.5 )ag/mL. Diluted sera were added to wells and incubated in
duplicate for 1 h at RT followed by 3 washes with PBS-0.1% Tween 20. HRPconjugated goat anti-mouse IgG (Fc-fragment specific) (Jackson ImmunoResearch
Laboratories, West Grove, PA), IgM, IgG l, IgG2a, IgG2b and IgGS (Caltag) were
diluted 2000-fold in PBS-0.1% Tween 20/1 %BSA and incubated for 1 hour at room
temperature followed by 3 washes with PBS-0.1% Tween 20. 100 pL One Step TMB
substrate (Zymed, San Francisco, CA) was added and incubated for 15 minutes followed
by the addition o f 100 pL 2N H 2 SO 4 to stop the reaction. The optical density was read at
450 nm and serum immunoglobulin concentration was calculated by extrapolation from
the linear portion o f the standard curve. All samples were tested in duplicate.
Cytokine Analysis
Cytokine levels were quantitated by use o f a Luminex based immunoassay from Linco
Research (St. Charles, MO). A 5-plex assay measuring IL-4, IL-10, lL-12, IFN-y and
TN F-a was used with serum and bronehoalveolar lavage fluid from saline and silica
treated NZM mice 14 weeks following instillation. The protocol provided by Linco
Research was followed and the samples were analyzed on a Luminex 100 instrument
(Luminex, Austin, TX).
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Flow Cytometry Analysis
Spleens and superficial cervical lymph nodes from 4 saline and 4 silica exposed NZM
mice were made into single cell suspension and washed 3 times with PBS. Purified rat
anti-mouse CD16/CD32 (Fcyll/III receptor) monoclonal antibody (Pharmingen, San Jose,
CA) was added to block Fc receptors. To identify the B cell populations, cells were
stained with FITC conjugated rat anti-mouse CD45R/B220 (Pharmingen), cy-chrome
conjugated rat anti-mouse CDS (ly-1) (Pharmingen), and R-phycoerythrin conjugated rat
anti-mouse CD23 (FceRII) (Pharmingen) monoclonal antibodies. T cell populations
were analyzed using cy-chrome conjugated rat anti-mouse CD3 (Pharmingen), Rphycoerythrin conjugated rat anti-mouse CD4 (Pharmingen) and FITC conjugated rat
anti-mouse CD25 (IL-2Ra) (Pharmingen). Antibodies were used at 1 pg/10^ cells. Cells
were acquired (10,000/sample) and analyzed on a Becton Dickenson FACScalibur flow
cytometer (Becton Dickenson, San Jose, CA). Cells that were B220+, CD5+ and
CD23'°'^ were classified as B la B cells (Mohan et al. 1998). Cells that were CD3+ and
CD4+ were classified as T helper cells and cells that were CD3+, CD4+ and CD25+ were
classified as regulatory T cells (Sakaguchi et al. 1995).
Statistical Analysis
Differences between saline and silica exposed mice were assessed using analysis o f
variance (ANOVA) and unpaired f-test. All values are reported as mean ± SE; p < 0.05
was considered significant.
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Results
Silica exposure leads to decreased IgG levels in N ZM mice
Changes in immunoglobulin levels have been reported in both human silicosis
patients and in several rat model o f silicosis (Doll et al. 1981; Huang et al. 2001;
Weissman et al. 2001). Similar to the previous results at 14 weeks, IgG levels were
significantly lower in silica-exposed mice than saline control mice (1639 pg/ml ± 193 vs.
3024 pg/ml ± 501 p<0.05) (Fig. 10) (Brown et al. 2003). Therefore, a more detailed
analysis of serum immunoglobulin levels was conducted at 14 weeks following silica
exposure in NZM mice, which included IgG, IgM, IgG l, IgG2a, lgG2b and IgG3 as
shown in Figure 10. IgG and IgM levels were also measured from 2 weeks to 14 weeks
following silica exposure, however there was no difference until the 14-week time point
(data not shown). IgM levels were slightly elevated in silica exposed NZM mice
compared to saline exposed mice (979 pg/ml + 213 vs. 792 pg/ml ± 104) (Fig. 10). IgG I
levels were significantly reduced in the silica-exposed mice compared to the saline
control mice (614 pg/ml ± 204 vs. 1124 pg/ml ± 224 /?<0.05) (Fig. 10). IgG2a, IgG2b
and IgG3 all remained at similar levels between the saline and silica exposed mice (Fig.
10). The resulting IgG2a:IgGI ratio was 1.36:1 suggesting a silica-induced shift towards
a Thl immune response.
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Figure 10:
Immunoglobulin levels measured by ELISA in NZM mice 14 weeks following silica
exposure. Serum levels o f IgG and IgG l were significantly decreased in silica exposed
NZM mice (n= 8 ) as compared to saline exposed control mice (n= 8 ). lgG2a levels
remained at normal levels following silica exposure, suggesting a normal T hl immune
response. The significant decrease in IgG l suggests a decrease in the Th2 immune
response. *(P<0.05)
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Silica exposure leads to increased TNF-a within the lungs o f N ZM mice
IL-4, IL-10, IL-12, TN F-a and IFN-y were examined using a Luminex based
mouse cytokine assay in order to assess changes in cytokine levels that may indicate
inflammation and a shift in the Thl/Th2 balance. We expected to see differences in
serum cytokine profiles that would suggest a Thl type immune response as seen with the
immunoglobulin levels. However, only small changes were seen in serum levels o f lL-10
(243 ± 7.9 pg/ml vs. 225 ± 4.9 pg/ml) and IL-12 (946 ± 5 1 .9 pg/ml vs. 887 ±21.1 pg/ml)
between saline and silica treated NZM mice (Fig. 11).
Significant differences in TN F-a levels within the bronchoalveolar lavage fluid
were observed in the silica exposed NZM mice. The silica treated NZM mice exhibited a
1.5-fold increase in TN F-a compared to the saline control mice 14 weeks following silica
exposure (50 ± 0 .1 9 pg/ml in saline exposed mice vs. 75 ± 1.85 pg/ml in silica mice
p<0.05) (Fig. 12). The increased levels o f TN F-a suggest silica is creating an
inflammatory environment and may result in excess apoptosis induced through the TNF
receptor mediated pathway (Pfeffer 2003).
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Figure 11:
IL-4, IL-10, IL-12, IFN-y and TN F-a levels within the serum o f saline (n= 8 ) and silica
(n= 8 ) exposed NZM mice 14 weeks following silica exposure. Cytokine levels were
measured using a Luminex based assay. There were slight differences in the levels o f IL10 and IL-12, however these differences are not biologically relevant.
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Figure 12:
TN F-a levels measured by a Luminex based assay o f bronchoalveolar lavage fluid 14
weeks following silica exposure in NZM mice. TN F-a was significantly increased 1.5
fold in silica exposed NZM mice (n=8) as compared to saline exposed mice (n=8). *
(F<0.05)
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Silica exposure results in an inerease in B220+ cells and B la B cell numbers in N ZM
mice
Due to the decrease in IgG and the alteration o f immunoglobulin isotypes, B cell
populations were examined 14 weeks following silica exposure in NZM mice. The
numbers o f B cells in the superficial cervical lymph node and spleen were analyzed by
flow cytometry. As shown in Table 1, the number and percentage o f cells expressing
B220 increased in the lymph nodes o f silica exposed NZM mice compared to saline
controls (5.41xl0^± 0.44 vs. 1.58xl0^± 0.09). Figure 13 shows a representative example
o f B cell staining from a saline (A) and silica (B) instilled mouse by flow cytometry. The
number of B220+ B cells also increased within the spleen o f silica treated NZM mice
from 5.71x10^ ± 1.49 cells in saline exposed mice to 6.82x10^ ± 1.08 B cells in silicaexposed mice (Table 1).
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Figure 13;
A representative example o f flow cytometric analysis o f B cells populations in the
superficial cervical lymph node o f saline (A) (n=4) and silica (B) (n=4) exposed NZM
mice. The number o f B220+ B cells increased significantly within the lymph nodes o f
silica exposed NZM mice as compared with the saline control mice (lower right gate).
The number and percentage o f B la B cells significantly increased in lymph nodes o f
silica exposed NZM mice compared to saline exposed mice (upper right gate).
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We next examined levels o f B la B cells since the NZM mouse model has been
reported to exhibit increased numbers o f B la B cells as compared to other strains o f mice
(Mohan et al. 1998). B la B cells have been implicated to play a role in the development
and progression o f autoimmune disease (Murakami et al. 1995; Mohan et al. 1998;
Berland et al. 2002). Following silica exposure, NZM mice significantly increased the
number o f B la B cells within the superficial cervical lymph node while decreased B la B
cells were seen in the spleen. The number o f B la B cells in the draining lymph nodes
increased from 0.305x10^ ± 0.04 cells in the saline treated mice to 1.75x10^+ 0.36 cells
in the silica treated mice (p<0.05) (Table 1). Since B la B cells have been reported to be
involved in autoimmune disease, the significant increase in B la B cells in the lymph
nodes suggest an additional mechanism for the exacerbation o f autoimmune disease
following silica exposure (Murakami et al. 1995; Mohan et al. 1998; Berland et al. 2002).
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Table 1. Distribution o f B cell subsets in the superficial cervical lymph node and spleen
w eeks fo llo w in g saline and silica exposure in N Z M m ice.

Site,
Treatment
Lymph Node
Saline
Siliea

Total B la B cells
xlO"(%)

Total B220+ cells
xlO'’(%)

1 .5 8 ± 0 .0 9 (1 2 .1 5 ± 0 .8 5 )
5.41 ± 0 .4 4 (1 8 .1 2 + 2 .6 5 )*

0.305 ± 0 .0 4 (2.35 ± 0 .51)
1.75 ± 0 .3 6 (5.75 ± 1.08)*

Spleen
Saline

5.71 ± 1.49 (40.81 ± 1 1 .8 6 )

1.27 ± 0 .1 8 (9.68 ± 1 .19)

Silica

6.82 ± 1.08 (35.81 ± 4 .3 7 )

0.952 ± 0 .1 2 (5.01 ± 0 .6 2 )
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14

Silica exposure results in increased CD4 T cell numbers and an altered regulatory T
cell.T helper cell ratio in N ZM mice
Results from the immunoglobulin data suggest a shift towards a Thl or T cell
mediated immune response; therefore, we examined increases in the CD4+ T helper cell
population 14 weeks following exposure to silica in NZM mice. The number o f CD4+ T
cells within the superficial cervical lymph node increased 6 fold following silica
exposure. The lymph nodes o f the saline control mice contained 6.37x10^10.49 CD4+ T
cells, while the silica treated mice contained 17.55x10^ ± 1.68 CD4+ T cells (p<0.05)
(Table 2). We previously reported an increase in the size o f the superficial cervical
lymph node following silica exposure (Brown et al. 2003) and now confirm that this
increase is mainly due to an influx o f CD4+ T helper cells. The number and percentage
o f CD4+ T cells within the spleens o f silica exposed NZM mice were not statistically
different as compared to saline exposed mice (data not shown). Figure 14 is a
representative example o f T cell staining in the superficial cervical lymph node o f a
saline (A) and silica (B) instilled NZM mouse showing an increase in the number the
number of CD4+ T cells in the upper right gate.
We further measured the number and percentage o f CD4+CD25+ regulatory T
cells to assess any changes that may be occurring within the regulatory capacity o f the
significant T cell mediated immune response observed within the lymph nodes o f silica
exposed mice. The percentage o f regulatory T cells decreased from 9.5% in the saline
exposed mice to 7.6% in the silica-exposed mice (Table 2). However, the numbers o f
regulatory T cells were minimally increased from 1.24x10^ ± 0.12 cells in the saline
exposed mice to 2.28x10^ ± 0.34 cells in the silica exposed mice (Table 2). The
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significant increase o f CD4+ T cells with a minimal increase in CD4+CD25+ regulatory
T cells alters the ratio o f f regulatory cells to T helper cells from a ratio o f 1:5 in the
saline exposed mice to 1:8 in the silica exposed mice (Table 2). This alteration o f the T
regulatory:T helper cell ratio may further allow the immune system to break tolerance
within the NZM mouse model following silica exposure.
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Figure 14:
A representative example o f flow cytometric analysis o f T cell populations within the
superficial cervical lymph node o f saline (A) (n=4) and silica (B) (n=4) exposed NZM
mice. The number and percentage o f CD4+ T helper cells significantly increased
following silica exposure in NZM mice (upper right gate). The CD4+ T helper cell
population was further analyzed for expression o f CD25 or the regulatory T cell
population. There was a slight increase in the number o f CD4+CD25+ regulatory T cells
in the silica-exposed mice. However the ratio o f regulatory T cells to T helper cells was
altered suggesting lack o f T cell regulation following silica exposure.
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Table 2. T cell populations in the superficial cervical lymph node 14 w eek s fo llo w in g saline and
silica exposure in N Z M m ice.

Site,
Treatment
Lymph Node
Saline
Silica

Total CD4+ T cells
xlO'^ (%)

Total CD4+CD25+
T cells x l O'’ (%)

1.24 ± 0 .1 2 (9.5 ± 0 .7 1 )
2.28 ± 0 .3 4 (7.6 ± 0 .7 5 )

6.37 ± 0 .4 9 (49.6 ± 3 .87)
17.55 ± 1.68 (58.5 ± 1 .2 2 )*

* (f< 0.05)
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Discussion
The increased incidence o f autoimmune disease following exposure to silica has
previously been reported, however, very few mechanistic studies have been done to
explore the mechanisms involved in this disease process. In this study, we utilized the
New Zealand mixed mouse model to examine changes in immunoglobulin and cytokine
levels as well as changes occurring within the B and T cell populations to try and bridge
the gaps o f knowledge existing between epidemiology studies and mechanistic studies o f
silica-induced autoimmunity.
Silica exposure has been associated with an increased incidence o f systemic
autoimmune disease and these patients have exhibited increased autoantibodies,
immunoglobulins and immune complexes (Doll et al. 1981; Wilke et al. 1996; Parks et al.
1999; Parks et al. 2002). Following silica exposure, NZM mice exhibit an exacerbated
autoimmune response as measured by increases in autoantibodies, glomerulonephritis and
pulmonary fibrosis (Brown et al. 2003). Due to these changes, we examined
immunoglobulins, cytokines and lymphocyte numbers to provide further insight into
mechanisms that may be involved in the exacerbation o f autoimmune disease following
silica exposure.
Previous results, examining immunoglobulin levels following silica exposure,
have reported an increase in Th2 type immunoglobulins in a rat model o f pulmonary
fibrosis (Huang et al. 2001; Weissman et al. 2001). However, in the present study we
examined alterations in immunoglobulin levels in a mouse model o f silica induced
autoimmune disease. Following silica exposure we previously reported that there was a
significant decrease in IgG levels 14 weeks following silica exposure in NZM mice
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(Brown et al. 2003). Due to this deerease in overall IgG levels, we examined several IgG
isotypes to determine if specific IgG isotypes account for the decrease in IgG. Following
silica exposure, IgG2a, indicative o f a T hl immune response, remained at the same levels
as saline control mice. However, IgG l, indicative o f a Th2 immune response was
significantly decreased in the silica instilled NZM mice as compared to the saline
instilled mice. The balance of IgG2a and IgG l seen following silica exposure in NZM
mice suggests an alteration in the balance o f the Thl/Th2 immune response in favor o f a
Thl or T cell mediated immune response.
Due to the immunoglobulin suggested alterations in the Thl/Th2 balance, we
examined cytokine levels within serum and bronchoalveolar lavage fluid (HALF) from
saline and silica treated NZM mice. However, there were only slight changes in serum
levels o f IL-4, IL-10 IL-12, IFN-y and TN F-a fourteen weeks following silica exposure.
The levels o f IL-4, IL-10, IL-12 and IFN-y were too low to detect within the BALF.
However, we saw a 1.5 fold increase in the levels o f TN F-a within the BALF o f silicainstilled mice as compared to the saline instilled mice. TN F-a has clearly been defined
has a mechanism o f inducing apoptosis (Pfeffer 2003). Apoptosis has been reported to
play a role in the development o f autoimmune disease, therefore a silica induced increase
in TN F-a may play a role in the exacerbation o f autoimmune disease we have proposed
by induction o f apoptosis in lung cells (Mevorach et al. 1998; Rosen et al. 1999;
Greidinger 2001; Brown et al. 2003).
We next examined B cell populations to explain the decrease in overall IgG
levels. We examined numbers o f B220+ B cells and B la B cells within the spleen and
superficial cervical lymph nodes. NZM mice have been reported to have an increased
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number o f B la B cells as compared to several other strains o f mice (Mohan et al. 1998).
Further, the B la B cell has been reported to play a role in the development and
progression o f autoimmune disease (Murakami et al. 1995; Mohan et al. 1998; Berland et
al. 2002). Fourteen weeks following silica exposure, NZM mice had significantly
increased numbers o f B220+ cells within the spleen and superficial cervical lymph node.
However, the numbers o f B la B cells were decreased within the spleen following silica
exposure as compared with the saline control mice. At the same time point the number o f
B la B cells increased 3 fold within a draining lymph node of the lung following silica
instillation. This suggests a pattern o f migration o f B la B cells from the spleen to the
superficial cervical lymph node. This increase in the number o f B la B cells may play a
major role in the development o f autoantibodies due to silica exposure. B la B cells have
been reported to have increased antigen presenting cell activity as measured by
phagocytosis and high expression levels o f CD80 and CD86 on their cell surface (Mohan
et al. 1998). Therefore, the B la B cells may aid in the development o f autoimmune
disease through phagocytosis o f apoptotic cellular material and subsequent presentation
o f autoantigens to T cells. Due to the reported increased expression o f CD80 and CD86
on the surface o f B la B cells, these cells potentially have an increased capacity to
activate autoreactive T cells further aiding the silica exacerbated immune response in
NZM mice (Mohan et al. 1998).
The number of CD4+ T helper cells increased 6 fold within the superficial
cervical lymph node 14 weeks following silica exposure. The number o f CD4+CD25+ T
regulatory cells increased minimally within the lymph node following silica exposure. It
is expected that as an increase in CD4+ T cells occurs, there should be a concomitant
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increase in CD4+CD25+ T regulatory cells to control the immune response and to
prevent autoreactivity (Sakaguchi et al. 1995; Takahashi et al. 1998; Shevach 2000;
Shevach 2002). However, following silica exposure, the balance o f regulatory T cells to
T helper eells was altered. It has been reported that the regulatory T cell population
constitutes approximately 10% o f the T cell population and this was true within our saline
exposed mice (Sakaguchi et al. 1995). However, following silica exposure, the
regulatory T cell population decreased within the lymph node from 9.5% to 7.6% o f the
total CD4+ T cell population. The change in the regulatory T cell and T helper cell
populations following silica exposure resulted in an altered ratio o f regulatory T cells to T
helper eells. Within the lymph nodes o f saline instilled miee, the ratio o f regulatory T
cells to T helper cells was 1:5, while the ratio in the silica exposed mice ehanged to 1:8,
suggesting a decreased ability to regulate T cell autoreactivity.
This significant increase in CD4+ T eells and altered balance o f regulatory T eells
following silica exposure, combined with a significant increase in B la B cells, may
provide an environment o f excess immune activation. This environment could then
become autoreactive by the addition o f excess apoptotic cellular material provided by
previously reported silica induced apoptosis o f macrophages and excess TN F-a induced
cellular apoptosis (Hamilton et al. 2000). The alterations in immunoglobulin, eytokine
and lymphocyte numbers reported in this study provide additional insights into possible
mechanisms that may be occurring within silica as well as other environmentally induced
autoimmune diseases.
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CHAPTERS
Silica-exposed mice generate autoantibodies to apoptotie cells
Abstract
Silica exposure has been assoeiated with development o f autoantibodies and
systemie autoimmune disease, but the meebanisms leading to these events are unknown.
This study was undertaken in order to test the hypothesis that apoptotic cells may provide
the epitopes for the exacerbated autoimmune responses in New Zealand Mixed (NZM)
mice following silica exposure. Apoptotic cells, but not live cells, were shown by
immunofluoreseenee mieroseopy and flow cytometry to stain brightly with serum from
ANA-positive mice, but they did not stain with ANA negative serum. Confocal
mieroseopy eolocalized staining by the serum antibodies with annexin V on apoptotic
blebs suggesting recognition o f epitopes on apoptotic cells by autoantibodies. In
addition, binding o f antibodies from ANA-positive miee was shown to he significantly
greater on cellular lysates from apoptotic cells, but not necrotic or live cell lysates using
an ELISA based assay. Finally, inhibition o f apoptosis with a caspase inhibitor, Boc-DFMK, blocked the increased binding by the autoantibodies. These results suggest that
apoptosis plays an important role in the development o f autoimmune disease in New
Zealand mixed mice by exposing antigenic epitopes to the immune system, and siliea is
able to exacerbate the disease process by induction o f excessive apoptosis.
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Introduction
Epidemiological studies have reported strong associations between silica exposure
and several autoimmune diseases, especially scleroderma (Reviewed in (Parks, Conrad et
al. 1999)). Increased levels o f serum immunoglobulins, immune complexes, and
autoantibodies have been demonstrated in bumans with silicosis (Doll, Stankus et al.
1981; Nigam, Sutbar et al. 1993). However, neither the mechanisms leading to humoral
changes nor their relationship to subsequent pathology have been elucidated.
Scleroderma (systemic sclerosis) is a chronic multisystem disease characterized by
fibrotic changes in affected tissues including the lung, and leading to a variety o f
symptoms that can be severely disabling. Silica-exposed individuals can develop a
systemic sclerosis that is very similar to idiopathic scleroderma (Haustein and Anderegg
1998). They also show inereased prevalence o f antinuclear antibodies (ANA), including
antibodies to topoisomerase (Scl70) and centromere proteins which appear to be
associated with subsequent development o f scleroderma (Haustein and Anderegg 1998).
The presence o f specifie antibodies associated with silica exposure provides evidence for
an immunologic etiology related to alterations in immune responses following silica
exposure (McHugh, Whyte et al. 1994).
Models o f autoimmunity suggest that at least two events must occur to generate
an autoimmune response: immune activation and the loss of peripheral T cell tolerance
leading to self recognition. This study was based on the hypothesis that silica exposure
alters the immune status in ways that meet both o f these criteria. Cells o f the lung
efficiently clear most respired particulates without residual damage. Silica, however,
leads to chronic inflammation and subsequent fibrosis, possibly due to disruption of
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alveolar macrophage (AM) function and excess production o f pro-inflammatory
cytokines (Davis, Pfeiffer et al. 1998). This adjuvant like effect o f silica has long been
recognized to have an effect on antibody production (Pernis and Paronetto 1962).
Therefore, exposure to silica clearly meets the first criterion in terms o f establishing an
immune activated/inflammatory environment.
Silica is quite cytotoxic, leading to both necrosis and apoptosis (Iyer, Hamilton et
al. 1996; Leigh, Wang et al. 1997), but it seems unlikely that cytotoxicity alone would
lead to a loss o f tolerance since the ingestion o f apoptotic bodies by phagocytes normally
down-regulates production o f inflammatory cytokines (Fadok, Bratton et al. 1998).
Instead, we have previously shown that silica appears to shift the population o f human
AM to a more immune active phenotype, through selective apoptosis o f the normally
immune suppressive AM population (Holian, Uthman et al. 1997; Hamilton, Pfau et al.
2001). Therefore, silica induces a highly inflammatory state in the exposed lung, in
addition to apoptosis o f alveolar macrophages. In this environment, excess apoptosis and
the inability to clear the apoptotic cells could lead to excess presentation o f self-antigens
therefore exacerbating an autoimmune response.
We have previously shown that silica exposure leads to exacerbated autoimmune
disease in the New Zealand Mixed (NZM) autoimmune-prone mouse, including
increased autoantibody production, immune complexes, proteinuria, pulmonary fibrosis
and glomerulonephritis (Brown, Archer et al. 2003). In order to test the hypothesis that
this autoimmune disease exacerbation may be associated with silica-induced apoptosis
and presentation of apoptotic antigens, serum from silica-exposed NZM mice was used to
demonstrate that antibodies were present which recognize epitopes on apoptotic
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macrophages.
Materials and Methods
Mice
Male and female New Zealand mixed (NZM 2410) mice were obtained from Taconic
(Germantown, NY) and maintained in microisolation containers in accordance with the
Guide fo r the Care and Use o f Laboratory Animals prepared by the Institute o f
Laboratory Animal Resources, National Research Council. The animal room was set on
12-hour dark/light cycles with food and water provided ad libitum. All protocols for the
use of animals were approved by the University o f Montana Institutional Animal Care
and Use Committee (lACUC).
Silica-instillation
Silica was obtained from Pennsylvania Glass Sand Corp. (Pittsburgh, PA) and was acid
washed, dried and determined to be free o f endotoxin by Limulus assay (Cambrex,
Walkersville, MD). At six weeks o f age, mice were instilled intranasally with either 30
pL saline or 30 pL saline suspensions o f 1 mg crystalline silica as previously described
(Brown, Archer et al. 2003). All mice received 2 instillations 2 weeks apart in order to
represent several exposures over a period o f time. Control and experimental groups were
matched for the number o f male and female mice. After 14 weeks, a time point when the
majority o f mice developed a positive ANA, the animals were euthanized with a lethal
injection o f Nembutal (200 pi ip), and blood was collected by cardiac puncture. Clotted
blood was centrifuged, and serum was collected and frozen at -20°C until use.
ANA
All serum samples were diluted 1:40 in PBS and tested by indirect immuno-fluorescence
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(IF) on commercially prepared and fixed HEp-2 cells (ImmunoConeepts, Sacramento,
CA). The staining pattern and relative fluoreseenee intensity were compared to known
positive and negative controls using a fluoreseenee microscope, and recorded as positive
(1+ to 4+) or negative. Anti-nuclear antibodies were also detected using ELISA kits for
mouse ANA (Alpha Diagnostics, San Antonio, TX) according to manufacturer’s
protocol.
Cells
MH-S cells, an alveolar macrophage Balb/C derived cell line (ATCC, Manassas, VA)
was used to generate apoptotic cells for IF and for ELISA cellular lysates. Cells were
cultured in RPMl with 10% FCS on tissue-culture treated multiwell slides (Cel-Line,
Portsmouth, NH) or multi-well culture plates, with eyeloheximide (0.1 mM, Calbioehem,
San Diego, CA) or silica (200 pg/ml) for 4 hr to induce apoptosis. Boe-D-FMK, a
broad-speetrum caspase inhibitor (Calbioehem) was used at 10 pM for 1 hr prior to
addition o f silica. This inhibitor was shown to block silica-induced apoptosis in MH-S
cells effectively to control levels, as detected by microscopic visualization o f apoptotic
morphology and by quantitation o f caspase 3 activity in cells grown on multi-well slides
(data not shown). Caspase 3 activity was measured on a laser scanning cytometer
(CompuCyte, Cambridge, MA) using rabbit anti-aetive caspase 3 (Promega, Madison,
W l) and goat anti-rabbit IgG conjugated with Alexafluor 488 (Molecular Probes, Eugene,
OR).
Staining fo r fluorescence/confocal microscopy and flo w cytometry
Cells were either plated on cell culture-treated slides for microscopy, mierotiter plate
wells, or 6 -well plates at 5x10^ eells/ml. The cells were treated with media or various
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treatments, blocked with PBS containing 2% BSA and Fc Block (5 gg/ml, Pharmingen,
San Jose, CA), then covered with PBS containing diluted serum (1:50) from ANApositive silica exposed mice or ANA negative saline exposed mice. After washing, anti
mouse IgG secondary antibody (2° Ab) conjugated to FITC was added (Pharmingen).
Then cells were counter-stained with either propidium iodide (PI, 5 pg/ml. Molecular
Probes) or annexin V conjugated to phycoerythrin (PE)(Pharmingen), to visualize
apoptotic cells by DNA fragmentation or phosphatidyl-serine exposure, respectively. For
fluorescence microscopy, the slides were washed, coverslipped, and analyzed on a Zeiss
fluorescence microcope. For microtiter assays, plates were centrifuged 5 min at 1500
rpm to prevent cell loss, washed gently 2 times and analyzed using a Spectra-Max
microtiter plate reader (Molecular Devices, Surmyvale, CA) set on 485 excitation and 530
emission. For flow cytometry, the cells were loosened from the wells and suspended in
PBS for analysis on a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA). A
minimum o f

10

"^ cells were analyzed in each sample.

Generation o f Apoptotic Cell Lysates
MH-S cells were grown to confluence in RPMI1640 and 10% FCS and either received no
treatment, repeated freeze-thaw cycles, 1 pg/ml eyeloheximide (Calbioehem) or 400
pg/ml silica. The cells were examined under light microscopy for morphological changes
indicative o f apoptosis before lysis. The cells were counted and a percentage o f total
cells undergoing apoptosis was recorded. MH-S cell pellets (lO’ cells) were incubated in
lysis buffer containing 150 mM NaCl, ImM MgCE, 80 mM Tris-HCl, 0.1% NP-40 and a
protease inhibitor cocktail (Roche, Marmheim, Germany). The lysates were passed
several times sequentially through 18 gauge to 25 gauge needles to ensure lysis o f the cell
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nuclei. Protein concentrations were determined after lysis using a Bio-Rad protein assay
(Bio-Rad, Hercules, CA) to ensure equal coating on a 96-well ELISA plates.
Cell Lysate ELISA
Ninety-six well Maxisorp Nalge-Nunc ELISA plates (Fisher) were coated with 100 pL of
1 pg/mL cell lysates in carbonate coating buffer. Plates were blocked with 200 pL PBS1% bovine serum albumin (BSA) for 2 hours at room temperature followed by 3 washes
with PBS-0.1% Tween 20. Serum was diluted 1:100 in PBS-0.1% Tween 20/1% BSA.
Diluted sera were added to wells and incubated in duplieate for 1 hour at room
temperature followed by 3 washes with PBS-0.1% Tween 20. HRP-conjugated goat anti
human IgG (H+L) (Jackson ImmunoResearch Laboratories, Philadelphia, PA) was
diluted 2000-fold in PBS-0.1% Tween 20/1 %BSA and incubated for 1 hour at room
temperature followed by 3 washes with PBS-0.1% Tween 20. One hundred pL One Step
TMB substrate (Zymed, San Francisco, CA) was added and incubated for 15 minutes
followed by the addition o f 100 pL 2N H 2 SO 4 to stop the reaction. The optical density
was read on a SpectraMax microtiter plate reader at 450 nm. All samples were tested in
duplicate or triplicate wells.
Statistics
Statistics were performed using GraphPad Prism software, and sets o f data were analyzed
against controls using an unpaired 2-tailed t test. A p value o f < 0.05 was considered
significant, and is represented as an asterisk. Error bars represent standard error o f the
mean o f a minimum o f 3 replicate samples. All experiments were performed
independently at least twice, with similar results.
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Results
Enhanced staining o f apoptotic cells with ANA-positive N ZM mouse serum
In order to demonstrate autoantibody binding to apoptotic cells, NZM mouse serum was
first determined to be ANA positive using HEp-2 ANA slides and a mouse ANA ELISA,
compared to positive controls. Silica-treated MH-S cells were used as the target cell,
representing an alveolar macrophage undergoing apoptosis after exposure to silica.
Immunofluorescent analysis o f the staining o f apoptotic macrophages with ANA-positive
serum showed an enhancement o f FITC intensity on cells undergoing nuclear blebbing as
visualized by propidium iodide staining o f the nucleus. Figure 15 shows an identical
field stained with both ANA-positive serum and FlTC-conjugated anti-mouse IgG
secondary antibodies (A), and propidium iodide to visualize the nucleus (B). The arrow
identifies a silica-induced apoptotic cell, showing nuclear fragmentation as well as
intense FITC staining. Moderate staining o f adjacent cells was more intense than that o f
cells stained with the secondary antibody alone (not shown), which could represent
exposure o f target epitopes on early apoptotic cells. Several fields were similarly
analyzed, and all cells with nuclear fragmentation showed similar increases in intensity o f
FITC staining. This suggests that cells undergoing this stage o f silica-induced apoptosis
may be exposing target epitopes for autoantibodies present in the autoimmune serum o f
the silica-treated mice.
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FIGURE 15
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Figure 15.
Visualization o f apoptotic cells stained with ANA-positive serum. MH-S cells plated on
tissue-eulture treated slides were treated with silica (200 pg/ml for 4 hr) to induce
apoptosis, fixed on the slides with 1 % paraformaldehyde, then stained with serum from
the ANA-positive silica-exposed mice (A). The cells were counter-stained with
propidium iodide to visualize the nucleus. The arrow identifies an apoptotic cell, showing
nuclear fragmentation with propidium iodide in the identical field (B). 400X
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Quantification o f apoptosis and serum antibody staining
To obtain a more quantitative measure o f the staining o f apoptotic cells, cells were
treated to undergo apoptosis, and then stained with ANA positive serum or aimexin V.
Annexin V can be used to identify apoptotic cells, due to its ability to bind to
phosphatidylserine, which moves to the outer membrane leaflet during apoptosis. Cells
were treated with eyeloheximide, which induces apoptosis through a caspase-dependent
pathway (Blom, de Bont et al. 1999; Tang, Lahti et al. 1999), and then stained with either
autoimmune serum (and FITC conjugated anti-mouse IgG secondary antibody) or
annexin V conjugated to phycoerythrin (PE). Figure 16 shows the staining o f cells
treated with media alone (filled) or containing eyeloheximide (open). Approximately
25% o f the untreated cells and 60% o f the eyeloheximide treated cells stained with
armexin V (Fig 16A), and similar percentages (30% and 68%, respectively) stained with
the autoimmune serum (Fig 16B). This suggested that the same cells undergoing
apoptosis were also staining with the autoimmune serum, and demonstrated that another
inducer o f apoptosis other than silica (eyeloheximide) could expose autoantigens on the
apoptotic cells.
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Figure 16.
Flow cytometric quantitation o f apoptosis and serum antibody staining o f cycloheximidetreated cells. Macrophages were treated with media alone (solid curves) or 0.1 mM
eyeloheximide (open curves) to induce apoptosis. Gates (M l) were set on FITC- or PEconjugated secondary antibody (Ab) staining alone, allowing <1% o f the cells in the
positive region o f the histogram. A; FITC (F L l) analysis o f media- and CHX-treated
cells stained with ANA-positive serum and FITC-conjugated secondary Ab. B: Annexin
V:PE (FL2) staining o f media- and CHX-treated cells. Histograms are representative o f 3
experiments.
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Co-staining o f apoptotic cells with autoimmune serum and annexin V
In order to quantify the apoptotic cells and demonstrate the specificity o f the enhanced
staining o f the apoptotic cells by the serum, MH-S cells were induced to undergo
apoptosis by exposure to silica, stained with ANA-positive or negative serum followed
by FITC-conjugated anti-mouse secondary antibodies, and then counter-stained with
armexin V:PE to identify the apoptotic cells. Figure 17 is a histogram which shows that
apoptotic cells (annexin V:PE+) stained with serum from ANA-positive mice (B) but not
from ANA-negative mice (A). In Figure 17, approximately 38% o f the cells were
apoptotic in both samples, above the horizontal quadrant marker set on live (untreated)
cells. Only 2% o f the total cell sample also stained with ANA-negative serum, whereas
27% were dual positive in the ANA-positive serum-stained sample (upper right
quadrant). This suggests that approximately 71% o f the apoptotic cells stained with the
serum antibodies above secondary antibody background staining and confirms the
specificity o f the staining to apoptotic cells. The data also shows that the staining was
not due to non-specific binding o f serum antibodies to the cells, since ANA negative
serum did not stain apoptotic cells.
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Figure 17.
Flow cytometric analysis o f dual staining o f apoptotic cells with the ANA-positive
serum. Apoptosis was induced with eyeloheximide in both samples, and then stained
with ANA-positive serum as the primary Ab and anti-mouse FITC-eonjugated 2° Ab, and
eounterstained with Annexin V:PE. Serum from an ANA-negative mouse did not eo-stain
the apoptotic cells (A). Co-staining o f apoptotic macrophages (Annexin V conjugated to
PE) is seen with serum from ANA-positive silica-exposed mouse (B). Gates were set on
2° Ab alone.
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Co-localization o f staining by serum and annexin V on apoptotic bodies and blebs
Because many autoantigens are cellular proteins exposed on apoptotic bodies and blebs,
confocal microscopy was used to determine whether autoimmune serum from silicaexposed NZM mice recognized apoptotic blebs. Figure 18 shows an apoptotic cell (MHS) that has been stained with ANA-positive serum and aimexin V:PE as in Figure 16.
Although some staining o f the whole cell occurred with both serum and annexin V, the
apoptotic bleb and bodies show the most intense staining by both stains consistent with
the proposed idea that the autoantibodies within serum from silica exposed NZM mice
recognize the silica-induced apoptotic MH-S cell.
Effect o f inhibition o f caspase activity on the staining with autoimmune serum
In order to further support the above evidence o f apoptosis-specific antigens being
exposed on the surface o f cells staining with autoimmune serum, apoptosis was blocked
with the broad-speetrum caspase inhibitor, Boc-D-FMK. Confirmation o f caspase 3
inhibition o f silica-induced apoptosis by Boc-D-FMK was performed as described in
Materials and Methods (data not shown). To measure the binding o f serum antibodies to
cells with and without inhibitor, cells were plated, treated with Boc-D-FMK at 10 pM 1
hr prior to the addition o f silica, and stained in 96-well plates after 4 hr. Figure 19 shows
significantly more fluorescence o f the silica-treated cells stained with autoimmune serum
compared to untreated cells, and a return to control levels with addition o f the caspase
inhibitor. This data shows that the staining o f eells by autoimmune serum is due to
recognition o f apoptosis-specific antigens on the surface o f the cells undergoing
apoptosis.
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FIGURE 18
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Figure 18.
Visualization o f staining o f apoptotic blebs with Annexin V and ANA-positive serum.
Using confocal microscopy, an apoptotic cell with associated blebs is shown stained with
serum from the ANA-positive silica-exposed mouse, where green is staining by serum &
FITC 2° Ab (A) and red is Annexin V-PE (B). Co-staining o f the apoptotic blebs with
serum antibodies is shown in C as an orange color. Oil emersion, 600X.
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Figure 19.
Blockage o f serum antibody binding by caspase inhibitor Boc-D-FMK. MH-S cells
plated in 96-well plates were treated with media alone, silica, or Boc-D-FMK plus silica
(with caspase inhibitor added 1 hr prior to silica). Plates were centrifuged to prevent cell
loss, and then stained with ANA-positive serum from silica-treated NZM mice. Counting
o f 40x microscope fields in the wells following staining showed that significant cell loss
had not occurred in any o f the wells. The plates were analyzed for FITC fluorescence on
a microtiter plate reader. Data is presented as mean fluorescence above staining by
secondary antibody control. Error bars represent standard error, n = 8, and * = p<0.05.
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Specificity o f the staining to antigens o f apoptotic, but not necrotic, cells
Both necrosis and apoptosis could potentially expose self-antigens to the immune system,
but the unique target epitopes seen in many autoimmune diseases suggest that the self
proteins are specifically altered during the process o f apoptosis to become antigenic. To
demonstrate the specificity o f the autoimmune serum antibodies to apoptotic cell
antigens, a cell lysate-based ELISA was developed. MH-S cells were either untreated or
treated with silica or eyeloheximide to induce apoptosis. Another sample o f cells was
frozen and thawed, to induce necrotic cell death. These samples were lysed and the
proteins were used to coat the ELISA plates. Binding o f serum antibodies from
autoimmune sera to the lysate proteins was then quantified as described in Methods. The
results shown in Figure 20 demonstrates significantly higher levels o f autoantibodies
bound the apoptotic cell lysates compared to untreated cells. Although there was an
increase in binding to the cycloheximide-treated cell lysate, this increase was not
significant. This interesting result suggests that the silica-induced apoptosis exposed
antigens that were not detected on the cycloheximide-treated cells, or were exposed to a
lesser degree. Overall, the data demonstrate that the major targets for autoantibodies
from the mice are antigens exposed on apoptotic, but not necrotic or live, cells.
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Figure 20.
ANA-positive serum binding to cellular targets specific for apoptotic, not necrotic cells.
MH-S cells were treated as described in Materials and Methods to induce apoptosis or
necrosis. Cells were lysed, protein quantified and coated on ELISA plates. Serum from
ANA-positive mice was used as primary antibody, and goat anti-mouse IgG conjugated
to horseradish peroxidase was added as the detection reagent. Color development after
addition o f substrate was analyzed by plate reader at 450 nm. Serum from silica-exposed
mice (solid bars, n=6) and serum from saline-only exposed mice (hatched bars, n=8).
Error bars represent standard error and * = p < 0.05 between saline and silica-treated
mice.

113

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Discussion
Although silica exposure is primarily associated with lung fibrosis, silica has also
been reported to trigger autoimmune responses and is associated with an increased
incidence o f systemic autoimmune disease. However, the meehanisms leading to these
autoimmune responses are not clear. A better understanding o f this proeess might
elucidate mechanisms that lead to other environmentally exacerbated autoimmune
diseases. Several mechanisms have been proposed whereby siliea might break peripheral
tolerance. The reported excess production o f sFas in silicosis could lead to self
recognition by inhibiting Fas-mediated apoptosis o f self-reactive immune cells (Otsuki,
Sakaguchi et al. 1998). However, this would not explain the source o f antigen that would
stimulate proliferation o f the self-reactive cells. One souree o f self antigen that might
break toleranee would occur with necrosis or apoptosis leading to excess self antigen
presentation on antigen presenting cells (APC). Rosen, et al., have shown that several
major autoantigens, including nucleosomal components, are exposed on apoptotic cells,
providing a possible mechanism o f presentation o f self antigens to the immune system
(Rosen and Casciola-Rosen 1999). Because apoptotic cells are normally cleared
effectively, immune responses against these antigens would not occur unless a condition
also existed that supported aetive antigen presentation activity. In the normal lung, most
inhaled particles and any damaged cells are cleared by alveolar macrophages (AM)
without chronic inflammation. However, silica exposure can alter the lung environment
in ways that lead to chronic inflammation and fibrosis. In humans, the effects o f silica
include a switch in phenotype to a much more active and pro-inflammatory phenotype o f
AM, possibly through selective apoptosis o f the more quiescent normal AM (Holian,
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Uthman et al. 1997; Hamilton, Pfau et al. 2001). Accumulation o f apoptotic AM plus the
switch to a more immune active environment may provide the necessary conditions for
an autoimmune response to occur.
In order to explore the mechanism o f the silica-exacerbated autoimmune disease,
this study used several techniques to demonstrate the presence in mice o f autoantibodies
in serum that recognize antigens on apoptotic macrophages. We have previously reported
that autoimmune-prone NZM mice exposed to crystalline silica exhibited significantly
higher titers o f antibodies to nucleosomal components and overall exacerbated systemic
autoimmune disease compared to saline or titanium dioxide (Ti0 2 , control particle)
instilled NZM mice (Brown, Archer et al. 2003). Because NZM mice develop
autoantibodies even without silica exposure, saline-exposed mice were selected that did
not produce positive ANA tests at 14 weeks o f age. This provided control samples that
gave background levels for non-specific staining. Serum antibodies from silica-exposed,
ANA-positive NZM mice bound to epitopes on cells that had been induced to undergo
apoptosis with silica, and stained more brightly than serum from saline-exposed ANAnegative NZM mice. This staining was prominent on apoptotic blebs and bodies,
suggesting that antigenic targets were exposed during the apoptotic process. The results
suggest that the exacerbation o f autoimmune disease by silica may be due to an increased
immune response to apoptotic antigens.
The staining o f apoptotic cells occurred not only when apoptosis was induced
with silica, but also with eyeloheximide. Both silica and eyeloheximide have been shown
to activate caspase-dependent apoptotic pathways in myeloid cells (Zhu, Feamhead et al.
1995; Chao, Hamilton et al. 2001). The ability o f autoimmune serum to stain cells
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undergoing cycloheximide-induced apoptosis suggested that the autoantigens in these
mice might be due to caspase activity that provided imique epitopes to the immune
system. Rosen et al (Rosen and Casciola-Rosen 1999) demonstrated that several nuclear
antigens are cleaved by caspases during apoptosis and are exposed on apoptotic cells and
blebs. Because many o f these nuclear antigens are common targets for autoantibodies,
their results suggested a mechanism o f unique self-antigen presentation. More recently,
data has accumulated that support both the ability o f apoptotic cells to serve as antigens
for autoantibody development (Mevorach, Zhou et al. 1998), as well as to involve
cleavage and re-localization o f important cellular components to which autoantibodies
are developed (Greidinger 2001; Nozawa, Casiano et al. 2002). The possibility that silica
leads to autoantigen exposure through caspase-dependent cleavage during apoptosis was
approached in two ways. First, if autoantibodies from silica-exposed mice were specific
for caspase-cleaved peptides, they should not recognize proteins on live or necrotic cells
to the same degree as apoptotic cells. In the current study, only the cell lysates from cells
undergoing silica-induced apoptosis showed significantly more binding by serum
antibodies than live cell lysates, although the binding to cells treated with cycloheximide
was also increased somewhat. This is consistent with results on surface staining o f
cycloheximide treated MH-S cells, and suggests that although some o f the autoantibodies
generated in silica-treated mice recognized antigens on cells triggered by different
apoptosis inducers, some o f the autoantibodies appear to recognize unique epitopes only
exposed on cells undergoing silica-induced apoptosis. This may provide an explanation
for some o f the specific autoantibodies found in silicosis patients. Second, if the
autoantibodies were binding to proteins uniquely cleaved by caspases or some
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downstream apoptotic event, caspase inhibition should reduce antibody binding by
blocking the apoptotic pathway leading to the protein cleavage. To test this hypothesis, a
broad-spectrum caspase inhibitor, Boc-D-FMK, was shown to prevent both silicainduced apoptosis and the increased binding o f serum autoantibodies from silica exposed
NZM mice to silica-treated cells.
Taken together, these data demonstrate that silica treatment o f NZM mice developed
autoantibodies that recognize caspase-cleaved proteins on apoptotic cells. The presence
o f antibodies to apoptotic cells provides clues to a possible mechanism leading to
autoimmune responses following silica exposure, in which accumulation o f apoptotic
cells in an inflammatory environment leads to presentation o f self-antigens and antibody
production.
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CHAPTER 4
Silica-induced apoptosis and systemic autoimmune disease is protein kinase C5
dependent
Abstract
Silica exposure has been assoeiated with formation o f autoantibodies and development o f
systemic autoimmune disease, but mechanisms leading to these events are unknown.
Silica exposure in autoimmune prone New Zealand mixed (NZM) mice results in a
significant exacerbation of systemic autoimmunity as measured by increases in
autoantibodies and glomerulonephritis. This study examined the role o f alveolar
macrophage apoptosis and protein kinase C6 (PKC6) in silica exacerbation o f systemic
autoimmune disease in NZM mice. Fourteen weeks following silica exposure, RNA and
protein levels o f PKC6 were significantly elevated in alveolar macrophages. To further
assess the role o f PKC6 in vivo, silica instilled NZM mice were treated with rottlerin, a
selective PKC5 inhibitor, onee a week. Fourteen weeks following siliea exposure, NZM
mice reeeiving only silica had increased levels o f anti-histone autoantibodies, proteinuria
and glomerulonephritis. However, silica instilled mice that received weekly instillations
o f rottlerin had significantly lower levels o f proteinuria, anti-histone autoantibodies and
complement C3 deposition within the kidney. Weekly instillations o f rottlerin in silica
instilled NZM mice also completely inhibited the upregulation o f PKC5 in alveolar
macrophages. Silica exposure in BALB/c bone marrow derived macrophages led to
increased protein levels o f PKC5 within 2 hours and by inhibiting PKC6 silica-induced
apoptosis was reduced. Here we report that silica induces PKC5 upregulation leading to
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apoptosis o f alveolar macrophages and by inhibiting this process in silica exposed NZM
mice, we significantly inhibited the exacerbation o f systemic autoimmune disease.
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Introduction
Silica is ubiquitous in the environment as an abundant mineral found in rock, sand
and soil. Silicosis is an occupational disease resulting from acute or chronic high levels
o f silica exposure that leads to decreased pulmonary function and increased susceptibility
to other diseases o f the respiratory tract (1997). Silicosis has also been associated with
increased incidence o f systemic autoimmune disease, such as systemic lupus
erythematosus (SLE) and scleroderma (Wilke 1996; Parks 1999; Parks 2002). Patients
with silicosis have increased autoantibodies, immunoglobulins and immune complexes
(Doll 1981). Although some o f the enhanced humoral response could be attributed to a
nonspecific adjuvant effect, the tendency towards select autoimmune diseases suggests a
more specific effect. Using autoimmune prone New Zealand mixed (NZM) mice, we
have previously reported that silica exposure significantly exacerbates the progression of
autoimmune disease (Brown 2003). Following silica exposure, NZM mice develop high
levels o f autoantibodies to nuclear antigen including histones, as well as developing
glomerulonephritis and pulmonary fibrosis within 14 weeks (Brown 2003).
Apoptosis has been reported to play a role in the initiation and progression of
systemic autoimmune disease and silica has been reported to induce a caspase specific
apoptotic response within alveolar macrophages (AM) (Iyer 1996; Mevorach 1998;
Rosen and Casciola-Rosen 1999; Lorenz 2000; Greidinger 2001; Gabler 2003; Thibodeau
2003). We have previously reported a possible role for apoptosis in the exacerbation o f
autoimmune disease in New Zealand mixed mice (Pfau 2004). Autoantibodies from
silica-exposed mice specifically recognize apoptotic cells and there appears to be greater
recognition o f silica induced apoptotic cells compared to live, necrotic or cycloheximide
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induced apoptotic cells (Pfau 2004).

Therefore we identified several apoptotic genes

induced in AM following silica exposure and focused on pro-apoptotic protein kinase C5.
Protein kinase C5 is a novel PKC family member that has been reported to play a
role in the initiation o f apoptosis in many cell types (Pongracz 1999; Webb 2000; Bertho
2002; Lounsbury 2002; Brodie and Blumberg 2003; Shukla 2003). PKC6 is activated by
diacylglyeerol/phorbol esters in a calcium-independent manner. PKC6 activation and
translocation are induced by a variety o f apoptotic stimuli in many different cellular
systems. PKC8 is activated in neutrophils undergoing spontaneous apoptosis, in H 2 O 2
induced apoptosis, TN F-a induced apoptosis. Fas mediated apoptosis and asbestos
induced-apoptosis o f alveolar epithelial cells (Pongracz 1999; Webb 2000; Bertho 2002;
Lounsbury 2002; Brodie and Blumberg 2003; Shukla 2003). PKC6 has been reported to
translocate to the nucleus and mitochondria following activation by the above-mentioned
mechanisms thereby inducing caspase activation (Gschwendt 1999; Kikkawa 2002;
Brodie and Blumberg 2003). Using rottlerin, a PKC6 selective inhibitor, these apoptotic
processes have been reported to be blocked (Gschwendt 1994; Gschwendt 1999;
Kikkawa 2002; Brodie and Blumberg 2003).
The overall objective o f this study was to test the hypothesis that PKC5 is
upregulated in alveolar macrophages following silica exposure leading to apoptosis.
Furthermore, we propose that by inhibiting the apoptotic process through PKC5 we can
decrease the severity of silica exacerbated systemic autoimmune disease in NZM mice.
This hypothesis was tested in vitro using silica treated bone marrow derived macrophages
and in vivo using silica exposed NZM mice.

Materials and Methods
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Mice
Male and female New Zealand mixed (NZM 2410) miee were obtained from Taconic
(Germantown, NY) and maintained in microisolation containers in accordance with the
Guide fo r the Care and Use o f Laboratory Animals prepared by the Institute of
Laboratory Animal Resources, National Research Council. The animal room was set on
12-hour dark/light cycles with food and water provided ad libitum. All protocols for the
use o f animals were approved by the University o f Montana Institutional Animal Care
and Use Committee.
Cells
BALB/c bone marrow derived macrophages were generated for in vitro use. BALB/c
mice were euthanized with a lethal injection o f Nembutal (200 pi ip) and the femur bones
were collected. Recovery o f the bone marrow cells was done within a sterile hood and
the cells were flushed from the bones using a 25-gauge needle. The cells were counted
and plated at 3xlO’ cells in 75 mm^ flasks. The cells were incubated overnight at 37°C
then the non-adherent cells were collected allowing removal o f stromal cells. The non
adherent cells were then re-plated in R PM l-1640/10% PCS and 10 ng/ml recombinant
mouse macrophage colony stimulating factor (R&D Systems, Minneapolis, MN). The
cells were allowed to differentiate into macrophages for 5-7 days before use. Cell
viability was determined to be >90% by trypan blue exclusion before treatments. Silica
was added at 250 pg/ml or 500 pg/ml for 2, 4 and 8 hours, untreated cells were used as a
control as well as Ti02 at 250 pg/ml and 500 pg/ml as a eontrol particle. Rottlerin (1
pg/ml) was added to bone marrow cell cultures 1 hour before addition o f 500 pg/ml o f
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silica. Cells were colleeted by seraping for generation o f protein lysates for use in
Western immunoblotting.
Apoptosis Assay
Apoptosis was determined by DNA fragmentation in bone marrow derived maerophages
using a TiterTacs Assay (R&D Systems, Minneapolis, MN). Manufaeturers protoeol was
followed. Equal numbers o f eells (IxlO^/well) were plated in a 96-well plate and allowed
to adhere overnight. Silica was added for 8 hours at 500 pg/ml with or without the
addition o f 1 pg/ml rottlerin 30 minutes prior. Non-treated cells were used as a negative
control and a nuclease generated positive control was used. Experiments were repeated 3
times. The reported values are mean optical density (OD) values from eaeh treatment.
Silica-Instillation
Silica was obtained from Pennsylvania Glass Sand Corp. (Pittsburgh, PA) and was acid
washed, dried and determined to be free o f endotoxin. At six weeks o f age, mice were
instilled intranasally with either 30 pL saline (n=6) or 30 pL saline suspensions o f 1 mg
crystalline siliea (n=6) or 500 pg Ti02 (n=6) as previously deseribed. All miee received
2 instillations 2 weeks apart. Control and experimental groups were matehed for the
number o f male and female mice. Alveolar macrophages were collected at 14 weeks for
use in microarray experiments. A second cohort o f mice was used to measure changes in
protein levels o f PKC5 and received 30 pL saline (n=4) or 30 pL saline suspensions o f 1
mg crystalline silica (n=4) or 500 pg TiOi (n=4). A third cohort o f mice was used for in
vivo inhibition o f PKC5 using rottlerin (A.G. Seientific, San Diego, CA), a PKC6
selective inhibitor (Gschwendt 1994; Davies 2000). Rottlerin was given at 10
pg/instillation and diluted in sterile saline; a volume o f 30 pL was used for intranasal
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instillation. Mice received either saline (n=5), silica (Im g x 2 instillations) (n=5), silica
(Im g X 2 instillations) + rottlerin (10 |ag/weekly instillation) (n=5) and rottlerin only (10
|j,g/weekly instillation) (n=5). Rottlerin was given intranasally 1 day before addition of
saline or silica and then again with the instillation o f saline or silica at six weeks o f age.
Rottlerin was then given once a week until the mice were sacrificed at 14 weeks. The
saline and silica only treated animals were given saline instillations once a week for 14
weeks as a control instillation to match the rottlerin instillations. After 14 weeks, a time
point when the majority o f silica exposed mice developed autoimmune disease as
measured by proteinuria and autoantibodies, the mice were euthanized with a lethal
injection o f Nembutal (200 |il ip), and blood was collected by cardiac puncture. Clotted
blood was centrifuged, and serum was collected and frozen at -20°C until use. Alveolar
macrophages were harvested from the lung by bronchoalveolar lavage for generation o f
protein lysates for use in Western immunoblotting and kidneys were removed and placed
in Histochoice fixative (Amresco, Solon, OH).
RNA Extraction and Amplification
RNA was extracted from 6 mouse bronchoalveolar lavage samples per condition (saline,
silica or Ti02 treatment) using Trizol (Invitrogen, Carlsbad, CA) with an extra
chloroform extraction following the initial chloroform step to further remove organics
from the final RNA product. Equal amounts o f the resulting RNA from each sample
within a condition were pooled and further purified and concentrated using RNeasy minipreps (Qiagen, Valencia, CA). Production o f amplified RNA (aRNA) was performed
using a RiboAmp kit (Arcturus, Carlsbad, CA).
Microarray Target Labeling and Hybridization
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For each sample, 5 pg o f aRNA and 10 pg o f Universal Mouse Reference RNA were
indirectly labeled with Alexa-fluor 647 or Alexa-fluor 555 respectively using Superscript
II (Invitrogen) reverse transcriptase according to the ARES DNA labeling kit protocol.
Labeled cDNA from reference RNA and aRNA were combined and hybridized overnight
in a 25% formamide hybridization buffer to an in-house cDNA microarray with 1178
different cDNA probes specific to mouse toxicology and immunology genes.
Microarray Analysis
Hybridized arrays were scanned with an Axon Genepix 4000B laser slide scanner and
visualized with GenePix Pro 4.0 software. Resulting result and image files were
imported into GeneTraffic Duo Microarray Data Management and Analysis Software
(lobion Informatics, La Jolla, C A) and normalized to a total 1:1 red to green ratio for the
entire slide. Data was filtered based on replicate quality, signal intensity and signal to
background ratios o f 1.2 or higher. An arbitrary cutoff o f 1.5-fold up- or downregulation was used to determine genes o f interest.
Histology
Kidneys were removed and placed into Histochoice fixative then routinely processed
using an automated processor (ThermoShandon, Pittsburgh, PA). The kidneys were
embedded in paraffin wax and sectioned 5-7 pM thick, then collected on poly-L-lysine
coated slides (Sigma Chemical, St. Louis, MO). The kidney sections were boiled in a
0.01 M sodium citrate buffer for 10 minutes followed by washes in distilled water and
phosphate buffered saline. The kidney sections were then blocked with 4% fetal bovine
serum in phosphate buffered saline. Goat anti-mouse IgG-FITC antibody (1 TOO) (ICN
Biomedicals, Irvine, CA) and a goat anti-mouse C3-FITC (1:100) (ICN Biomedicals,
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Irvine, CA) were added for 4 hours for the detection o f immune complexes and
complement deposition. A goat anti-rat IgG antibody (1:100) (ICN Biomedicals, Irvine,
CA) was used as an isotype control. Samples were blinded and examined using a
confocal microscope.
Urinary Protein
Proteinuria was measured by Chemstrip 2 GP test strips as described by the manufacturer
(Boehringer Mannheim Diagnostics, Indianapolis, IN). Milligram protein per deciliter
was measured between groups following the provided scale (0 ==negative, trace, 1+ = 30
mg/dL, 2+ = 100 mg/dL, 3+ = 500 mg/dL).
Detection o f Serum Autoantibodies
Anti-histone autoantibodies were detected using an ELISA kit (Alpha Diagnostics, San
Antonio, TX). Sera were diluted 100-fold before assay and the manufacturer’s protocol
was followed. The reported values are mean optical density (OD) values from each
treatment group.
Western Immunoblots
Western immunoblots were performed using lysates generated from alveolar
macrophages collected by bronchoalveolar lavage and from bone marrow derived
macrophages. Lavage cells were collected and determined to be between 75-90%
alveolar macrophages and an equal number o f cells were lysed using a 0.5% Nonidet P40 detergent (Sigma, St. Louis, MO) with freshly added complete protease inhibitors: 10
pg/ml pepstatin, 10 pg/ml leupeptin, 10 pg/ml aprotonin and ImM phenylmethylsulfonyl
fluoride (PMSF) (Roche, Indianapolis, IN). Bone marrow cells were collected by
scraping followed by the same lysis treatment. Samples were kept on ice during lysis and
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frozen immediately at -20°C until use. Protein concentrations o f lysates were determined
using a Bio-Rad protein assay (Bio-Rad, Hercules, CA) and equal concentrations o f
lysates were loaded onto Invitrogen 12% Nu-PAGE gels (Carlsbad, CA) followed by
transfer onto nitrocellulose (Bio-Rad). Nitrocellulose blots were probed using an
antibody to PKC6 (1:300) (BD Transduction Laboratories, San Diego, CA). Purified
PKC5 (Oxford Biomedical Research, Oxford, MI) was used as a positive control.
Detection o f antibody to PKC6 was performed using goat anti-mouse IgG-HRP (1 :2000)
(Jackson Immunoresearch, West Grove, PA). Detection o f positive bands was done
using an enhanced chemiluminesence reagent (Amersham, Piscataway, NJ) and
visualized using a VersaDoc imaging system (Bio-Rad). Experiments using BMDM
were repeated 3 times. Densitometry was performed using Quantity One software (BioRad) to quantitate differences between bands. Numbers reported are density
(intensity/mm^).
Statistical Methods
Statistical analysis was done using the software package PRISM, v. 3.03 (GraphPad, San
Diego, CA). Differences between saline, Ti02 and silica treated mouse groups was
assessed using an unpaired two-tailed /-test. Differences between controls, silica
treatments and rottlerin treatments o f bone marrow derived macrophages were assessed
using a one-way analysis o f variance (ANOVA). All values are reported as mean +
SEM; p < 0.05 was considered significant.
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Results
P K C d is upregulated in alveolar macrophages from silica exposed N ZM mice
Silica exposure has been reported to induce apoptosis in several cell types,
however, the signaling cascade leading to the apoptotic response is not fully defined
(Hamilton 2000; Chao 2001; Thibodeau 2003). Therefore, alveolar macrophages were
collected from silica exposed NZM mice to screen for changes in apoptotic genes using
microarray technology. Using an in-house microarray chip with 1200 immunology and
toxicology genes, we identified several genes involved in apoptosis that were upregulated
1.5 fold or higher following silica exposure o f which PKCd was the most prominent.
Fourteen weeks following 2 instillations o f 1 mg silica, the RNA levels o f PKCd were
elevated 2.4-fold as compared to saline instilled mice. TiOi did not elevate the levels o f
PKCd RNA as compared to the saline control mice. Similar to the RNA results, PKCd
protein levels were also found to be significantly elevated in silica exposed mice
compared to saline and TiOi exposed mice (4921 + 357 int/mm^ versus 2571 + 333
int/mm^ and 1805 ± 256 int/mm^; p < 0.05, respectively) (Fig. 21). These results indicate
that PKCd RNA and protein levels were both increased long term in alveolar
macrophages following silica exposure in NZM mice. Consequently, the rest o f the study
examined the potential role o f PKCd in silica-induced autoimmune disease in NZM mice.
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FIGURE 21
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Figure 21.
Western blot analysis for PKC5 in alveolar macrophage cellular lysates from saline
(n=4), Ti02 (n=4) and silica (n=4) instilled NZM mice 14 weeks following exposure.
Densitometry shows a 2-fold increase in PKC5 levels as compared to saline and TiOa
exposed mice. Equal concentrations o f protein were added per lane. * Significant
differences between silica exposed mice and saline or Ti02 controls (p < 0.05).
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PK C S levels are increased follow ing silica exposure in bone marrow derived
macrophages
To further examine the role o f PKC6 in alveolar macrophage apoptosis, an in
vitro model using bone marrow derived macrophages (BMDM) was utilized. PKCd
levels were significantly increased 5-fold within 2 hours following treatment with 500
pg/ml silica as compared to an untreated control (1766 ± 177 int/mm^ versus 3 1 1 1 1 3
int/mm^; p < 0.001, respectively) (Fig. 22). Ti02 (250 and 500 pg/ml) did not increase
the levels o f PKCd as compared to an untreated control (404 ± 93 int/mm^ and 359 ± 40
int/mm^ versus 311 ± 13 int/mm^, respectively) (Fig. 22). The levels o f PKCd began to
decrease within 4 and 8 hours after silica exposure, a time point at which cells began to
die and float into the media (Fig. 22). To inhibit PKCd, rottlerin was added to the media
o f the BMDM culture 1 hour before the addition o f silica. Figure 22 demonstrates that
addition o f 1 pg/ml rottlerin inhibited the induction o f PKCd by silica at 2 hours for the
500 pg/ml silica exposure (302 1 4 0 int/mm^ versus 1766 1 177 int/mm^; p < 0.001,
respectively). Treatment o f BMDM with rottlerin alone did not have an effect on the
levels o f PKCd at 2 hours (Fig. 22). Apoptosis o f silica treated BMDM was determined
by measuring DNA fragmentation. Figure 23 shows a 500 pg/ml silica treatment induced
a 3-fold increase in apoptotic cells within 8 hours as compared to an untreated control
and was significantly reduced by the addition o f rottlerin (1.074 ± 0.084 versus 0.325 ±
.073 versus 0.663 + 0.091; p < 0.05, respectively). However, if cells are treated with 500
pg/ml silica for greater than 12 hours, rottlerin does not inhibit apoptosis (data not
shown). These results demonstrate that BMDM provide a good in vitro model to
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examine the role o f PKCS in silica-induced apoptosis o f alveolar macrophages and that
rottlerin can delay apoptosis in silica treated cells.
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Figure 22.
Western blot analysis for PKC5 in bone marrow derived macrophages. Cells received no
treatment, 250 and 500 pg/ml TiOi, 250 and 500 pg/ml silica from 2, 4 and 8 hours, 500
pg/ml silica + 1 pg/ml rottlerin for 2 hours or 1 pg/ml rottlerin only for 2 hours. Silica
exposure increases PKC6 levels within 2 hours and decreases around 8 hours following
exposure. Densitometry shows a significant increase in the level o f PKC5 with 500
pg/ml silica exposure at 2 hours, adding rottlerin completely inhibited the silica induced
upregulation o f PKC6. Equal concentrations o f protein were added per lane.
Representative example from 1 o f 3 separate experiments. * Significant differences
between silica treated BMDM and no treatment, TiOi treatments, silica + rottlerin
treatments or rottlerin only treatments (p < 0.001).
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Figure 23.
Determination o f apoptosis measuring DNA fragmentation. BMDM received no
treatment, 500 pg/ml silica for 8 hours, 500 pg/ml silica + 1 pg/ml rottlerin or 1 pg/ml
rottlerin only. Rottlerin reduced the amount o f apoptosis in silica treated BMDM. *
Significant differences between siliea treated BMDM and untreated BMDM and silica ■
rottlerin treated BMDM (p < 0.05).
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Rottlerin treatment decreases severity o f silica-exacerbated systemic autoimmune disease
in N ZM mice
As previously described, silica exposure in NZM miee results in a significant
exacerbation o f systemic autoimmune disease within 14 weeks, however, the role that
silica-induced apoptosis may play in the exacerbation o f the autoimmune disease has not
been elucidated (Brown 2003). Based on the results above demonstrating the role of
PKC5 in silica-induced apoptosis in vitro and the ability o f rottlerin to inhibit this
process, the role o f silica-induced apoptosis was examined in vivo. Therefore, NZM mice
were exposed to saline, 2 instillations o f 1 mg silica, 2 instillations o f 1 mg silica and 10
pg rottlerin or 10 pg rottlerin alone. Rottlerin instillations were given one day prior to
siliea instillation then onee a week for 14 weeks. Similar to the results in Figure 21,
PKCS levels in alveolar macrophages lavaged from siliea only treated NZM mice at 14
weeks were significantly increased compared to saline control mice (2887 ± 643 int/mm^
versus 249 ± 44 int/mm^; p < 0.001, respectively) (Fig. 24). However, instillation o f
rottlerin onee a week for 14 weeks significantly decreased the levels o f PKCS expression
in siliea treated mice as compared to mice receiving only silica (606 + 124 int/mm^
versus 2887 + 643 int/mm^; p < 0.001, respectively) (Fig. 24).
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Figure 24.
Western blot analysis for PKC6 in alveolar macrophages collected from saline (n=5),
silica (Im g X 2 instillations) (n=5), silica (Im g x 2 instillations) + rottlerin (10 pg/weekly
instillation) (n=5) and rottlerin only (10 pg/weekly instillation) (n=5) treated NZM mice
14 ^veeks following exposure. Silica exposure upregulated the levels o f PKC5 14 weeks
following exposure, however, weekly instillation o f rottlerin completely inhibited PKC5
activation by silica. Equal concentrations o f protein were loaded per lane. * Significant
differences between silica exposure and saline, silica + rottlerin or silica + rottlerin (p <
0.001).
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As previously reported, silica exposure in NZM mice resulted in increased
proteinuria and severe immune complex and complement deposition within the kidney
(Brown 2003). Proteinuria levels greater than 500 mg/dl were seen in 3 out o f 5 (60%) o f
the silica treated mice 14 weeks post-instillation; however, no proteinuria was observed
in silica-instilled mice that were treated with rottlerin once a week for 14 weeks (Fig. 25).
Proteinuria was observed in 1 out o f 5 mice receiving rottlerin only treatments (Fig. 25).
Kidneys from these mice were examined for IgG immune complex and complement C3
deposition. Figure 26 shows increased complement C3 deposition within the glomerulus
o f silica-exposed mice as compared to the saline control mice as previously reported
(Brown 2003). Silica exposed mice receiving rottlerin instillations once a week for 14
weeks showed less extensive C3 deposition within the glomerulus (Fig. 26). IgG
immune complex deposition was also examined and similar staining as the C3 deposition
was seen (data not shown).
As previously reported, silica exposure in NZM mice results in a significant
increase in the levels o f anti-nuclear autoantibodies, including anti-histone autoantibodies
(Brown 2003). Development o f anti-histone autoantibodies was significantly increased
in silica exposed NZM mice at 14 weeks as compared to saline control mice (0.392 ±
0.086 versus 0.187 ± 0.034; p < 0.05, respectively) (Fig. 27). However, instillation o f
rottlerin significantly decreased the levels o f anti-histone autoantibodies within silica
exposed NZM mice as compared to mice that received only silica (0.159 ± 0.045 versus
0.392 ± 0.086; p < 0.05, respectively) (Fig. 27). The levels o f anti-histone autoantibodies
in NZM mice treated with rottlerin only were also significantly lower than saline controls
(0.106 ± 0.007 versus 0.187 ± 0.034; p < 0.05, respectively) (Fig. 27).
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Therefore, instillation o f rottlerin in silica exposed NZM mice significantly
reduced the levels o f PKC6 in AM and decreased proteinuria, C3 deposition in kidneys
and the levels o f anti-histone autoantibodies. Taken together, silica exacerbation o f
systemic autoimmune disease was significantly inhibited by blocking PKC5 in vivo.
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Figure 25.
Percentage o f mice with 500 mg/dL proteinuria levels in saline (n=5), silica (Im g x 2
instillations) (n=5), silica (Im g x 2 instillations) + rottlerin (10 pg/weekly instillation)
(n=5) and rottlerin only (10 pg/weekly instillation) (n=5) treated NZM mice 14 weeks
following exposure as measured by use o f ChemStrip 2GP glucose/proteinuria strips.
Sixty percent o f silica exposed mice developed high proteinuria, while none o f the saline
or silica + rottlerin instilled mice developed high proteinuria.
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FIGURE 26
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Figure 26.
Representative examples o f immunohistochemical staining o f kidney sections for
complement C3 deposition from (A) saline (n=5), (B) silica (Im g x 2 instillations) (n=5),
(C) silica (Im g x 2 instillations) + rottlerin (10 pg/weekly instillation) (n=5) and (D)
rottlerin only (10 pg/weekly instillation) (n=5) treated NZM mice 14 weeks following
exposure. A goat anti-mouse C3-FITC antibody was used to stain for complement
deposition within the glomerulus o f the kidney. The silica exposed mice showed
complement deposition within the glomeruli (h), however, weekly rottlerin instillations
inhibited the silica-induced complement deposition (e). Saline and rottlerin only instilled
mice showed very little staining for complement deposition. Representative example o f 1
out o f 5 mice per group. Magnification 20X.
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FIGURE 27
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Figure 27.
Development o f anti-histone autoantibodies in saline (n=5), silica (Im g x 2 instillations)
(n=5), silica (Im g x 2 instillations) + rottlerin (10 |ag/weekly instillation) (n=5) and
rottlerin only (10 p-g/weekly instillation) (n=5) treated NZM mice 14 weeks following
exposure as measured by ELISA. Silica exposure significantly elevated the levels o f
anti-histone autoantibodies in NZM mice 14 weeks following silica exposure. However,
weekly instillations o f rottlerin in silica-instilled mice inhibited the development o f high
levels o f anti-histone autoantibodies. The values reported are mean OD values for each
treatment group. * Significant differences between silica exposed mice and saline or
silica + rottlerin exposed mice (p < 0.05). ^ Significant differences between saline
exposed mice and saline + rottlerin exposed mice (p < 0.05).
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Discussion
Silica exposure has been reported to induce autoimmune responses and is
associated with an increased incidence o f systemic autoimmune disease (1997; Parks
1999; Parks 2002). However, the mechanisms leading to these autoimmune responses
are not understood. Elucidating these mechanisms may provide a better understanding o f
other environmentally relevant exposures implicated in triggering autoimmune responses
as well as providing directions for novel therapies.
Possible mechanisms o f silica induced autoimmune disease may involve the
alveolar macrophage, an immune cell o f the lung that is the first line o f defense. It has
previously been reported that silica exposure leads to a caspase dependent apoptosis of
alveolar macrophages (Iyer 1996; Thibodeau 2003). Silica induced apoptosis o f alveolar
macrophages leads to release and uptake o f silica by other alveolar macrophages,
producing a cyclical process o f inflammation and cell death (Cooper 2002). This
constant inflammation and cellular death may provide excess antigen that is being
presented to the immune system, thereby breaking immune tolerance.
Studies by Rosen, et al have reported concentrated autoantigens within the blebs
of apoptotie cells (Rosen and Casciola-Rosen 1999). Lupus autoantigens are represented
by structures that are chemically cleaved or modified during apoptosis and if this material
is not removed by non-inflammatory processes, apoptotie material could be presented by
specialized antigen presenting cells to induce immune responses (Utz and Anderson
1998; Ronehetti 1999). In an in vitro system, macrophages were found to prevent
immunity to apoptotie material by competing with dendritic cells for uptake o f apoptotie
blebs, demonstrating the importance o f the cell population silica is targeting for injury
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(Albert 1998). Consistent with the hypothesis, mice intravenously exposed to apoptotie
cellular material have been reported to develop autoantibodies (Mevorach 1998).
In this study, a cDNA microarray specific for mouse toxicology and immunology
genes was used with RNA from alveolar macrophages collected from silica exposed
NZM mice to analyze for expression changes in genes involved in the apoptotie process.
Silica exposure in NZM mice induced several genes involved in apoptosis, including
thymosin plO, PKC6, TN F-a induced protein-6, and Bcl-2 like protein. PKC5 RNA
levels were increased more than the other genes; therefore, we focused on the role PKC6
plays in silica-induced apoptosis and autoimmune disease. It appears that PKC8 is being
increased by silica exposure and remains increased long term, possibly through release o f
TN F-a (Emoto 1995). Concurrent with this hypothesis, we have previously reported a
significant increase in TN F-a levels within the lung lavage fluid o f silica treated NZM
mice 14 weeks following silica exposure (Brown).
To further assess the role o f PKC5 in alveolar macrophage apoptosis, we utilized
an in vitro model using BALB/c bone marrow derived macrophages. Using bone marrow
derived macrophages we demonstrated a significant increase in the levels o f PKC5 within
2 hours following 500 pg/ml silica exposure, while untreated cells and TiOa treated cells
had low levels o f PKC6. Measuring DNA fragmentation we demonstrated that silica
induces apoptosis o f BMDM and this process can be delayed by the addition o f rottlerin.
Silica exposure has previously been reported to induce mitochondrial cytochrome c
release leading to a caspase-mediated apoptosis o f macrophages (Thibodeau 2003).
Further, PKC5 has been reported to migrate to the mitochondria following exposure to
asbestos and H 2 O 2 resulting in altered mitochondrial membrane permeability, thereby
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activating caspases (Majumder 2001; Shukla 2003). Silica has also been reported to
mediate it’s apoptotie effects through the scavenger receptor, therefore it appears silica
can induce apoptosis by several different pathways and by inhibiting one pathway via
PKC5 we can delay the onset o f apoptosis in macrophages (Hamilton 2000).
To test our hypothesis that PKC8 mediated apoptosis o f alveolar macrophages
plays an important role in the exacerbation o f systemic autoimmune disease by silica, we
utilized weekly intranasal instillations o f rottlerin to inhibit PKC6 and delay silica
induced apoptosis. We have previously reported that intranasal instillation o f siliea in
autoimmune-prone NZM mice results in a significant exacerbation o f autoimmunity 14
weeks following instillation as measured by increases in mortality, proteinuria,
autoantibodies and glomerulonephritis (Brown 2003). NZM mice typically do not
develop high levels o f autoantibodies and glomerulonephritis until around 6 months of
age (Rudofsky and Lawrence 1999). However, following silica exposure, NZM mice
develop high levels o f autoantibodies and severe immune complex and complement
deposition within the kidney around 14 weeks (Rudofsky and Lawrenee 1999; Brown
2003). As previously reported, NZM mice in this study that received only silica
instillations developed high proteinuria (60% o f the mice), high levels o f anti-histone
autoantibodies and excess immune complex and complement C3 deposition in the
kidneys (Brown 2003). Silica exacerbated systemic autoimmune disease was
significantly reversed by blocking PKC8 with weekly rottlerin instillations. Silica
exposed NZM mice receiving weekly instillations o f rottlerin did not develop high levels
o f proteinuria, anti-histone autoantibodies or severe immune complex or complement C3
deposition within the kidney. Weekly rottlerin instillations decreased PKC8 levels in
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alveolar macrophages from silica exposed NZM mice down to levels seen in saline
instilled mice. These significant findings suggest that one pathway o f silica-induced
apoptosis mediated by PKC5 plays a major role in silica exacerbated autoimmune
disease.
Taken together, these data demonstrate that silica exposure induces the
upregulation o f PKC5 within alveolar macrophages thereby inducing apoptosis. More
importantly, inhibiting PKC6 upregulation in vivo significantly decreases the
exacerbation o f systemic autoimmune disease by silica exposure. These findings may
provide additional mechanisms for other relevant xenobiotics that induce apoptosis and
provide additional insight into the importance o f apoptosis in autoimmune disease. More
importantly, these results may provide possible therapeutic approaches to the treatment o f
environmentally mediated autoimmune diseases.
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CONCLUSIONS
These studies examined mechanisms by which silica is able to exacerbate the
progression o f systemic autoimmune disease in New Zealand mixed miee. As diseussed
earlier, siliea exposure has been associated with several autoimmune diseases in human
populations including systemic lupus erythematosus, rheumatoid arthritis and
scleroderma (Steenland and Brown 1995; Parks, Conrad et al. 1999; Parks, Cooper et al.
2002; Parks, Cooper et al. 2003). However, very few studies have examined mechanisms
by which silica may initiate or exacerbate these autoimmune diseases. Further, many
animal studies with silica exposure have focused on the development o f fibrosis and lung
inflammation and while these mechanisms may be relevant for the development o f
autoimmune disease, very little data exist specifically examining silica-induced
autoimmunity. Therefore, this project begins to fill the gaps o f knowledge that exist in
understanding mechanisms o f silica exposure and the development o f autoimmune
disease. The goals o f this project were to characterize the exaeerbation o f autoimmune
disease by silica and to examine the role o f silica-induced apoptosis in the exacerbation
o f autoimmunity.
Silica exposure resulted in the exacerbation o f systemie autoimmune disease in
NZM mice. The most pronounced response to silica in NZM mice was decreased
survival. The silica exposed mice died significantly earlier than saline or Ti02 exposed
mice. Further, mortality corresponded to the development o f high levels o f proteinuria
suggestive o f renal failure. Silica particles have been reported to accumulate within the
kidney, however, the increase in autoantibodies and immune complexes within our model
suggested immune complex and complement mediated glomerulonephritis (Slavin,
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Swedo et al. 1985). Therefore, kidneys were examined for immune complex and
complement C3 deposition within the glomerulus o f silica exposed NZM mice. Fourteen
weeks following silica exposure, glomeruli from silica exposed NZM mice had higher
levels o f immune complex and complement C3 deposition suggesting that decreased
survival in silica-exposed NZM mice was due to renal disease. These results further
provide evidence that a localized exposure to silica in the lung can lead to and have
detrimental effects systemically.
This study found increased levels o f autoantibodies to nuclear antigen, which
included increased levels o f anti-dsDNA and anti-histone autoantibodies in silicaexposed NZM mice as compared to saline and Ti02 exposed mice. These autoantibodies
have also been reported in silicosis patients with autoimmune disease (Parks, Cooper et
al. 2002). The autoantibody repertoire within silica exposed NZM mice included
autoantibodies that preferentially recognized apoptotie cells rather than live or necrotic
cells. Several studies have reported an important role for apoptosis in the development
and progression o f autoimmune disease (Huggins, Todd et al. 1999; Rosen and CasciolaRosen 1999; Lorenz, Herrmann et al. 2000; Greidinger 2001; Gabler, Kalden et al. 2003).
Therefore, it appears the apoptotie process may play a major role in silica-induced
exacerbation o f autoimmunity by exposing self-antigens that are not normally presented
to the immune system.
Following silica exposure, NZM mice had lower levels o f IgG as well as
alterations in immunoglobulin isotypes suggestive o f a Thl type immune response.
These findings were similar to studies done in rat silicosis models in which a shift to a
T hl response was reported (Huang, Hubbs et al. 2001; Weissman, Hubbs et al. 2001).
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Due to the alterations in IgG and immunoglobulin isotypes, lymphocytes were examined
in siliea exposed NZM miee. B cell numbers were not decreased as suggested by the
decreased IgG levels, thereby indicating that IgG is being deposited in tissues as was
evidenced by deposition within the kidneys. There was an increase in the number o f B la
B cells in the superficial cervical lymph node in silica exposed NZM miee. NZM miee
have been reported to have an expanded population o f B la B cells within the peritoneal
cavity, therefore it appears silica is inducing the migration o f these cells to regional
lymph nodes o f the lung (Mohan, Morel et al. 1998). Further, B la B cells are reported to
be very potent antigen presenting cells, therefore, these cells may aid in the progression
o f autoimmune disease by presenting self-antigen to T cells (Mohan, Morel et al. 1998).
T helper cells were also examined within lymph nodes o f silica-exposed mice and were
significantly increased in number as compared to saline exposed miee. These results
were similar to what has been reported in human silicosis patients and other animal
models (Watanabe, Shirakami et al. 1987; Friedetzky, Gam et al. 1998). The percentage
o f regulatory T cells was decreased in lymph nodes o f siliea exposed NZM miee mainly
due to the large increase in T helper cells. Taken together, these data suggest siliea
exposure led to the migration o f B la B cells and T helper cells to local lymph nodes as
well as a decrease in regulatory T cells, therefore allowing for excess antigen presentation
which may aid in the progression o f systemic autoimmunity.
To further examine the role o f macrophage apoptosis in siliea exacerbated
systemie autoimmune disease, a mieroarray analysis o f 1200 genes was performed on
RNA collected from alveolar macrophages that were harvested from saline, TiOi and
silica exposed NZM mice. Several genes involved in apoptosis were upregulated in
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alveolar macrophages in response to silica exposure in NZM mice. These increases in
RNA included; protein kinase C5 (PKC5), thymosin (310, TN F-a, Bcl-2 like protein and
several MAP kinases. Protein kinase C5 was the most prominent increase in silica
exposed NZM mouse alveolar macrophages, therefore, the role o f PKC8 in apoptosis and
autoimmunity was further examined. Fourteen weeks following silica exposure, the
levels o f PKC8 RNA and protein were significantly increased as compared to saline and
TiOa exposed mice. Using bone marrow derived macrophages as an in vitro model
representing alveolar macrophages, we demonstrated that silica induced an increase in
PKC6 within 2 hours and declined by 8 hours. Using rottlerin, a selective inhibitor o f
PKC8, the levels o f PKC6 were decreased in silica-exposed cells. Further, treatment o f
the silica-exposed bone marrow derived macrophages with rottlerin reduced the level o f
apoptosis as compared to cells exposed only to silica. Therefore, it appears PKC6 is
contributing to the induction o f apoptosis following silica exposure in macrophages.
These results were similar to the reported effects o f asbestos on the activation o f PKC6 in
alveolar epithelial cells followed by caspase-9 activation and subsequent apoptosis
(Shukla, Stern et al. 2003). Due to the ability o f rottlerin to reduce the level o f apoptosis
in silica exposed cells and the possible role o f apoptosis in the progression of
autoimmune disease, rottlerin was used in vivo to inhibit silica-induced apoptosis o f
alveolar macrophages. Silica exposed NZM mice receiving weekly rottlerin instillations
for 14 weeks had decreased proteinuria, kidney disease and anti-histone autoantibodies as
compared to mice receiving only silica. Therefore, it appears that by reducing silicainduced apoptosis via PKC5 o f alveolar macrophages within NZM mice, we significantly
reduced the exacerbation o f systemic autoimmune disease by silica exposure.

160

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Summary
Using autoimmune-prone New Zealand mixed mice, this study investigated the
exacerbation o f systemic autoimmune disease by crystalline silica exposure. Results
from silica exposure in NZM mice demonstrated that silica is able to exacerbate systemic
autoimmune disease within a genetically susceptible murine model. Silica exposure in
NZM mice resulted in increased mortality due to immune complex and complement
deposition within the kidney. Silica exposed mice had increased levels o f autoantibodies
as compared to saline and Ti02 exposed mice. Further, autoantibodies from silicaexposed mice preferentially recognized apoptotie cells. Silica exposure was shown to
increase levels o f pro-apoptotic protein kinase C5 within alveolar macrophages which
played a major role in the exacerbation o f autoimmunity. Taken together, these results
suggest that silica-induced apoptosis o f alveolar macrophages plays a significant role in
the exacerbation o f systemic autoimmune disease.
Our proposed model, shown in Figure 28, suggests that inhalation o f crystalline
silica results in concurrent activation and apoptosis o f the alveolar macrophage resulting
in an environment o f inflammation and recurrent apoptosis. This environment may
provide excess antigen that is further ingested by activated macrophages or dendritic cells
which are able to migrate to local lymph nodes. Within the lymph nodes, these antigenpresenting cells laden with apoptotie material activate T cells and B cells thereby
inducing an autoimmune response. The poor ability o f the body to clear silica from the
lung prolongs this cycle of macrophage apoptosis and lymphocyte activation, thereby
progressing from an autoimmune response into a systemic autoimmune disease.
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Significance

Very little data exist in regards to mechanisms o f silica exposure and the
development o f autoimmune disease, therefore these results are significant in that they
represent one o f the first identified mechanisms by which silica exposure may be
inducing or progressing the development o f autoimmune disease. As discussed
previously, the concordance o f autoimmune disease among twins is only 25-40%,
therefore, along with genetics, environmental factors may play a large role in the
initiation and progression o f autoimmunity. This study examined the ability o f silica to
exacerbate systemic autoimmune disease, however, similar mechanisms may be relevant
in other environmental exposures such as asbestos, mercury, organic solvents and
pharmaceuticals. In addition to environmentally induced autoimmune disease, these
results further define the importance o f the regulation o f apoptosis in the immune system.
Future Directions
We filled several gaps o f knowledge in regards to mechanisms by which silica
can initiate or progress the development o f systemic autoimmunity, however, several
future directions need to be addressed. We demonstrated increased recognition o f
apoptotie cells by autoantibodies from silica exposed NZM mice, however, the antigens
involved have not been identified. It is possible that silica-induced apoptosis may result
in the specific cleavage or alteration o f antigen that is then recognized as foreign by the
immune system. Therefore, identification o f the antigens in apoptotie cells that we
demonstrated are recognized by the immune system may provide unique biomarkers to
identify autoimmune diseases that may have an environmental origin.
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We demonstrated that PKC6 is involved in silica-induced apoptosis o f alveolar
macrophages, however, it remains unknown how PKC6 is being activated by silica
exposure. Since blocking PKC5 only delayed the onset o f apoptosis and did not
completely inhibit it in vitro, it appears several pathways of apoptosis are activated by
silica exposure. Further, it remains unknown how these pathways may interact or if
additional apoptotie pathways are involved. Understanding the complete mechanisms by
which silica induces apoptosis provides a means to further define cellular signaling
pathways and provides insight into mechanisms o f other xenobiotics which induce
apoptosis.
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FIGURE 28
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Figure 28.
A diagram o f the proposed model o f silica-exacerbated systemic autoimmune disease in
the NZM mouse.
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